var title_f41_21_42320="RTT unique hand pattern";
var content_f41_21_42320=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67899&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67899&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rett syndrome, unique hand pattern",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    As typically happens from age one to four years in RTT, this girl had onset of midline hand stereotypes that occur incessantly during wakefulness but cease during sleep.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Glaze DG, Schultz RJ. Rett syndrome: meeting the challenge of this gender-specific neurodevelopmental disorder. Medscape Women's Health 1997; 2. Copyright &copy; 1997 Medscape.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42320=[""].join("\n");
var outline_f41_21_42320=null;
var title_f41_21_42321="Hysteroscopic surgery PI";
var content_f41_21_42321=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F75492&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F75492&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 496px\">",
"   <div class=\"ttl\">",
"    Hysteroscopic surgery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 476px; height: 601px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hysteroscopic surgery can be used to remove abnormal growths in the uterus, or to do a number of different procedures on the uterus and vagina. In this example, abnormal growths called fibroids are being removed from the uterus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42321=[""].join("\n");
var outline_f41_21_42321=null;
var title_f41_21_42322="Holoprosencephaly spectrum";
var content_f41_21_42322=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70880&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70880&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 521px\">",
"   <div class=\"ttl\">",
"    Holoprosencephaly spectrum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 501px; height: 557px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     Features of cebocephaly include an absent or defective single-nostril nose and closely set eyes (hypotelorism). Ethmocephaly is characterized by small, narrow-set eyes (hypotelorism and microphthalmia) separated by a primative, nonfunctioning nasal structure (proboscis). Cyclopia is marked by a single&nbsp;central orbital fossa&nbsp;and proboscis. The globe can be absent, underdeveloped or apparently normal, and there can be one or two globes.",
"    </p>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42322=[""].join("\n");
var outline_f41_21_42322=null;
var title_f41_21_42323="Cefditoren: Patient drug information";
var content_f41_21_42323=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Cefditoren: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/19/38196?source=see_link\">",
"     see \"Cefditoren: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F147246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Spectracef&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015451\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bacterial infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015450\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701738",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to cefditoren or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have low carnitine levels.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015455\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696830",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take antacids with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea). Yogurt or probiotics may help. You may get these products at health food stores or in some pharmacies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015458\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015453\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10015454\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015460\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11850 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-2F5800EE8D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42323=[""].join("\n");
var outline_f41_21_42323=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147246\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015451\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015450\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015455\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015456\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015458\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015453\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015454\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015459\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015460\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?37/19/38196?source=related_link\">",
"      Cefditoren: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_21_42324="Anatomy SC IJ central line";
var content_f41_21_42324=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F74801&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F74801&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Anatomy of the subclavian and internal jugular veins",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 436px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42324=[""].join("\n");
var outline_f41_21_42324=null;
var title_f41_21_42325="M-mode of right ventricular hypertrophy";
var content_f41_21_42325=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F73683&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F73683&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    M-mode of right ventricular hypertrophy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 424px; height: 234px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    M-modes of right ventricular hypertrophy taken from the precordial long axis window. The right ventricular (RV) wall thickness from the echocardiogram in the left panel is difficult to measure because of hypertrophy. Saline contrast helps to differentiate trabeculation from the hypertrophied free wall (FW) (right panel).",
"    <div class=\"footnotes\">",
"     IVS: interventricular septum; PWLV: posterior wall of the left ventricle; MV: mitral valve.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42325=[""].join("\n");
var outline_f41_21_42325=null;
var title_f41_21_42326="Radiation effects prost CA bx";
var content_f41_21_42326=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F64711&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F64711&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Radiation therapy effects on prostate adenocarcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 297px; height: 574px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The variability in the histologic appearance of prostate cancer following radiation therapy is illustrated by these high power photomicrographs of two hematoxylin and eosin stained tissue sections from the same patient. Top panel: this area of the biopsy is characterized by marked histologic change, with the tumor cells demonstrating significant degenerative changes and atrophy. The cytologic atypia can hardly even be recognized (arrowheads). Bottom panel: in contrast, tumor cells from a different area of the same specimen from the same irradiated patient shown in the above panel demonstrates the characteristic cytologic atypia of prostate cancer (arrows) without significant atrophic changes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ximing Yang, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42326=[""].join("\n");
var outline_f41_21_42326=null;
var title_f41_21_42327="Classification of migraine in children";
var content_f41_21_42327=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Classification of migraine in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/21/42327/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/21/42327/contributors\">",
"     Robert P Cruse, DO",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/21/42327/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/21/42327/contributors\">",
"     Marc C Patterson, MD, FRACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/21/42327/contributors\">",
"     Jerry W Swanson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/21/42327/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/21/42327/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/21/42327/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Migraine is the most common acute and recurrent headache syndrome in children. It is characterized by periodic episodes of paroxysmal headache accompanied by nausea, vomiting, abdominal pain, and relief with sleep.",
"   </p>",
"   <p>",
"    This topic will review the classification of migraine in children. Other aspects of migraine are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/25/8600?source=see_link\">",
"     \"Pathophysiology, clinical features, and diagnosis of migraine in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/3/18490?source=see_link\">",
"     \"Management of migraine headache in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORICAL ASPECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 1988 classification of headaches by the International Headache Society (IHS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/1\">",
"     1",
"    </a>",
"    ] did not specifically address children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/2\">",
"     2",
"    </a>",
"    ]. This system replaced the terms \"classic and common\" with the terms \"with and without aura.\" Migraine was classified into migraine with aura, migraine without aura, complicated migraine, and migraine variants.",
"   </p>",
"   <p>",
"    In 1997, the IHS revised the classification and diagnostic criteria for migraine in children younger than 15 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/3\">",
"     3",
"    </a>",
"    ]. In a multicenter evaluation of the standard and revised criteria, diagnostic rates of pediatric migraine were better with the revised criteria (93 versus 66 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/4\">",
"     4",
"    </a>",
"    ]. Use of the revised criteria also improved diagnostic rates in the subset of patients less than 12 years of age (87 versus 49 percent).",
"   </p>",
"   <p>",
"    In 2004, the IHS issued an overall revision of the classification of headaches (",
"    <a class=\"graphic graphic_table graphicRef50876 \" href=\"mobipreview.htm?11/31/11773\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/5\">",
"     5",
"    </a>",
"    ]. The term \"Complicated migraine\" was replaced by \"Complications of migraine\", and several disorders were eliminated or reclassified [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2004 IHS revisions affect some syndromes unique to children that historically were considered manifestations of migraine. These syndromes - cyclical vomiting, abdominal migraine, benign paroxysmal vertigo of childhood - are usually associated with a positive family history and often evolve into more characteristic migraine symptoms with age. They are now considered \"childhood periodic syndromes that are commonly precursors of migraine\" in the revised International Headache Society (IHS) classification system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Childhood periodic syndromes'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Some of the other disorders discussed here, including Alice in Wonderland syndrome and confusional migraine, are not addressed in the latest IHS classification. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Migraine variants'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Ophthalmoplegic migraine is now thought to arise from a recurrent demyelinating neuropathy. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Ophthalmoplegic migraine'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MIGRAINE WITHOUT AURA",
"    </span>",
"    &nbsp;&mdash;&nbsp;In migraine without aura, formerly known as common migraine, patients typically have a prodrome consisting of pallor, an alteration in personality, or a change in appetite or thirst. The prodrome may precede the headache by several hours.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MIGRAINE WITH AURA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Migraine with aura was formerly known as classic migraine. Approximately 14 to 30 percent of children report an aura preceding a migraine, although the incidence may be underestimated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Auras and prodrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Auras represent progressive neurologic deficits or disturbances with subsequent complete recovery. Visual disturbances are the most common type, accounting for the majority of the neurologic symptoms associated with migraine. Numbness and tingling of the lips, lower face, and fingers of one hand (cheio-oral) is the second most common type of aura. Auras may also involve other senses or occasionally cause motor or speech deficits. Some patients have several types of aura symptoms that vary with attacks.",
"   </p>",
"   <p>",
"    Auras are classified into the following types:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ophthalmic",
"     </li>",
"     <li>",
"      Hemiparesthetic",
"     </li>",
"     <li>",
"      Hemiparetic",
"     </li>",
"     <li>",
"      Hemiplegic",
"     </li>",
"     <li>",
"      Aphasic",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the International Headache Society (IHS) terminology, ophthalmic aura is used to denote any migrainous disturbance of vision [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Typical aura",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the revised IHS terminology, a typical aura consists of visual",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    speech",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sensory symptoms (",
"    <a class=\"graphic graphic_table graphicRef50876 \" href=\"mobipreview.htm?11/31/11773\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/5\">",
"     5",
"    </a>",
"    ]. Additional features of a typical aura include gradual development, duration no longer than one hour, a mix of positive and negative features, and complete reversibility. If the aura includes motor weakness, the migraine is classified as familial hemiplegic migraine or sporadic hemiplegic migraine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H698850692\">",
"    <span class=\"h2\">",
"     Hemiplegic migraine",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary feature that separates hemiplegic migraine from other types of migraine with aura is the presence of motor weakness as a manifestation of aura in at least some attacks. The clinical aspects of hemiplegic migraine are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/60/17354?source=see_link\">",
"     \"Hemiplegic migraine\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hemiplegic migraine may occur either in families or only in one individual (sporadic). Familial hemiplegic migraine (FHM) is defined as migraine with aura that includes motor weakness in a patient who has at least one first or second degree relative who also has migraine aura that includes motor weakness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/5\">",
"     5",
"    </a>",
"    ]. The first three types of FHM are channelopathies numbered according to the gene involved. FHM1 is caused by mutations in the CACNA1A gene, FHM2 by mutations in the ATP1A2 gene, and FHM3 by mutations in the SCN1A gene. Mutations in the PRRT2 gene also cause some cases of familial hemiplegic migraine. The known types of familial hemiplegic migraine account for only a small proportion of cases. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/60/17354?source=see_link&amp;anchor=H81876416#H81876416\">",
"     \"Hemiplegic migraine\", section on 'Familial hemiplegic migraine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Basilar-type migraine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Basilar-type migraine is discussed in detail separately and reviewed here briefly. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/44/44743?source=see_link\">",
"     \"Basilar-type migraine\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Basilar-type migraine is a rare form of migraine with aura wherein the primary signs and symptoms are referable to either the brainstem or both cerebral hemispheres without weakness. Although more common in females, basilar-type migraine may affect both genders. Onset is usually between ages 7 to 20. Attacks may evolve to more typical common forms of migraine with age. The auras of basilar-type migraine consist of some combination of vertigo, dysarthria, tinnitus, diplopia, bilateral visual symptoms, bilateral paresthesias, decreased level of consciousness, or hypacusis.",
"   </p>",
"   <p>",
"    Basilar-type migraine should be diagnosed only when weakness is absent, since about 60 percent of patients with familial hemiplegic migraine (see",
"    <a class=\"local\" href=\"#H698850692\">",
"     'Hemiplegic migraine'",
"    </a>",
"    above) have basilar-type symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/6\">",
"     6",
"    </a>",
"    ]. Differential diagnosis includes acute ataxia of childhood, toxic ingestion, or posterior fossa structural lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CHILDHOOD PERIODIC SYNDROMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the revised IHS criteria published in 2004, the childhood periodic syndromes are considered as conditions that are commonly precursors of migraine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/5\">",
"     5",
"    </a>",
"    ]. These include cyclical vomiting syndrome, abdominal migraine, and benign paroxysmal vertigo of childhood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cyclical vomiting syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cyclical vomiting syndrome (which often occurs with abdominal migraine) is a disorder characterized by repeated episodes of nausea and vomiting that last for hours to days, separated by symptom-free periods of variable length [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. The protracted vomiting may lead to severe volume depletion and the need for intravenous therapy.",
"   </p>",
"   <p>",
"    Headache is not a typical feature. Clinical symptoms are not associated with electroencephalographic changes.",
"   </p>",
"   <p>",
"    Symptoms often begin in young children and typically stop spontaneously at puberty, although some adolescents are affected. The differential diagnosis includes acute gastrointestinal conditions such as obstruction or pancreatitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/48/34568?source=see_link\">",
"     \"Cyclic vomiting syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Abdominal migraine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abdominal migraine is characterized by recurrent episodes of abdominal pain in a previously healthy child who is normal between attacks. The pain is typically midline or poorly localized, dull and moderate to severe in intensity; headache is not a prominent feature during attacks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/8\">",
"     8",
"    </a>",
"    ]. Photophobia or phonophobia are not common. Temperature elevation and diarrhea do not occur. Abdominal pain is associated with at least two additional features that may include anorexia, nausea, vomiting, and pallor. Protracted vomiting is more consistent with cyclic vomiting. Precipitating factors are often searched for but not commonly identified; concerns often include dietary and psychological stress.",
"   </p>",
"   <p>",
"    Abdominal migraine affects 2 to 4 percent of children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/8\">",
"     8",
"    </a>",
"    ], and 4 to 15 percent of children with chronic periodic abdominal pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/10\">",
"     10",
"    </a>",
"    ]. The age at presentation is usually between 2 to 10 years.",
"   </p>",
"   <p>",
"    Abdominal migraine is a clinical diagnosis; there are no confirmatory diagnostic tests. The diagnosis with the first event is challenging. The many causes of acute abdominal pain need to be considered in the differential diagnosis with the first attack. Testing is determined by the history and physical examination but the search for a mechanical process such as obstruction, kidney disorder, infection or metabolic condition may be in order. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/20/11593?source=see_link\">",
"     \"Causes of acute abdominal pain in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pathophysiology of abdominal migraine is uncertain, with consideration to central nervous system, endocrine imbalance, or ionic channel disorders. A genetic factor is suggested; 60 percent are said to have a positive family history of migraine.",
"   </p>",
"   <p>",
"    Management remains empiric. Excluding serious abdominal conditions and making the correct diagnosis of migraine may provide some reassurance to the family. Good sleep habits, proper hydration, avoidance of foods high in amines or xanthines, and avoidance of stressful situations when possible may be helpful. Although data are limited regarding pharmacologic treatment for abdominal migraine, analgesics such as",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/48/7946?source=see_link\">",
"     ibuprofen",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/15/19705?source=see_link\">",
"     acetaminophen",
"    </a>",
"    may be useful as abortive therapy if given early during an attack. Antiemetics are indicated if there is significant nausea or vomiting. During an attack, medication administered by suppository is preferable. Daily preventive medication is usually reserved for the child with frequent attacks. Nonanalgesic migraine medications such as",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/62/36840?source=see_link\">",
"     propranolol",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?40/2/40996?source=see_link\">",
"     cyproheptadine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/15/40181?source=see_link\">",
"     pizotifen",
"    </a>",
"    (the latter not available in the United States) may be effective as prophylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. There are also case reports of abdominal migraine responsive to triptans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/13\">",
"     13",
"    </a>",
"    ] and to intravenous valproic acid given in the emergency room [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/3/18490?source=see_link\">",
"     \"Management of migraine headache in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The long-term prognosis is good for the intermittent abdominal pain. Most children stop having attacks by early adolescence, but rarely attacks may persist into adulthood. However, most children with abdominal migraine evolve to develop migraine headaches. In one study of 54 children with abdominal migraine who were followed for 7 to 10 years, current or previous migraine headache was identified in 70 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/15\">",
"     15",
"    </a>",
"    ]. The prognosis for the clinical course of migraine headache in such children is thought to be similar to migraine that develops without preceding abdominal spells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Benign paroxysmal vertigo of childhood",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benign paroxysmal vertigo of childhood is the most frequent cause of dizziness in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/16\">",
"     16",
"    </a>",
"    ]. The disorder often presents when the child is a toddler, although may be manifest later in childhood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/17\">",
"     17",
"    </a>",
"    ]. Affected patients may suddenly appear frightened or unable to walk and will hold on for support. Children may experience decreased alertness or loss of strength. In a report of school children in Scotland, benign paroxysmal vertigo was usually accompanied by features common in migraine, including nausea, pallor, phonophobia, and photophobia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/18\">",
"     18",
"    </a>",
"    ]. Migraine was twice as common in first-degree relatives of affected children compared with unaffected children.",
"   </p>",
"   <p>",
"    Episodes are usually brief, lasting only a few minutes, but may cluster, with recurrence of attacks several times within a few hours. Headache typically does not occur. The disorder resolves spontaneously after several episodic attacks. However, typical migraine may develop in later life in some patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/19\">",
"     19",
"    </a>",
"    ]. The differential diagnosis includes toxic ingestion and primary middle ear disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     RETINAL MIGRAINE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Retinal migraine is a rare disorder. It is characterized by a sudden loss of vision or the perception of bright light (photopsia) or scintillations in one eye only, followed within one hour by a migrainous headache [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/20\">",
"     20",
"    </a>",
"    ]. The neurologic symptoms are fully reversible. The headache is typically ipsilateral and periorbital. Visual symptoms may occur without headache. Vision usually recovers in this condition, although permanent visual loss may occur.",
"   </p>",
"   <p>",
"    Funduscopic examination in this condition is abnormal. The retina appears pale and retinal vessels may be constricted.",
"   </p>",
"   <p>",
"    The IHS prefers the term retinal migraine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/5\">",
"     5",
"    </a>",
"    ], but ocular migraine is a more precise term, since both retinal and ciliary circulations may be involved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     COMPLICATIONS OF MIGRAINE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of migraine include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chronic migraine",
"     </li>",
"     <li>",
"      Status migrainosus",
"     </li>",
"     <li>",
"      Persistent aura without infarction",
"     </li>",
"     <li>",
"      Migrainous infarction",
"     </li>",
"     <li>",
"      Migraine-triggered seizure",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A prolonged aura is characterized by a focal neurologic deficit that lasts beyond the resolution of the migraine attack; prolonged aura was previously considered under the rubric of \"complicated migraine.\" Under the IHS classification revised in 2004, prolonged auras are now divided into three categories based on the duration of aura or presence of infarction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Migraine with prolonged aura (if the aura lasts more than one hour but less than one week with normal brain imaging).",
"     </li>",
"     <li>",
"      Persistent aura without infarction (if the aura lasts more than one week with no evidence of infarction).",
"     </li>",
"     <li>",
"      Migrainous infarction (if the deficit lasts more than one hour and the neuroimaging shows an infarction).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Migrainous infarction and the relationship of headache, migraine and stroke are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32953?source=see_link\">",
"     \"Headache, migraine, and stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     MIGRAINE VARIANTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Alice in Wonderland syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alice in Wonderland syndrome is characterized by headache that is preceded or accompanied by visual hallucinations, bizarre perceptual distortions (eg, of body image), or impairment of time sense [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/22\">",
"     22",
"    </a>",
"    ]. The child is not frightened and can describe the experience without amnesia. The perception disorder lasts from several days to months, and children typically recover without sequelae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/23\">",
"     23",
"    </a>",
"    ]. The syndrome can affect patients of any age, although it is more common in young people [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Migrainous ischemia and cortical irritability is thought to be the etiology in most cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/24\">",
"     24",
"    </a>",
"    ]. However, Alice in Wonderland syndrome has also been reported after viral encephalitis and as an epileptic phenomenon. In a series of 10 patients from Taiwan, ages three to ten years, nine had upper respiratory tract infections two days to four weeks prior to development of symptoms; the remaining patient had chickenpox three days previously [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/23\">",
"     23",
"    </a>",
"    ]. Epstein-Barr virus has been implicated in some cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Confusional migraine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with confusional migraine have a headache that is typical of migraine associated with symptoms of agitation, disorientation, and aphasia that last longer than the headache. Confusional episodes tend to recur, but are eventually replaced by typical migraine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical features of confusional migraine were described in a series of 13 patients who were hospitalized for migraine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/27\">",
"     27",
"    </a>",
"    ]. Children ranged in age from 6 to 15 years (mean 10.8 years), and males predominated (11 males, 2 females). The duration of confusion was 2 to 24 hours. History was positive for mild head trauma (four patients), agitation (eight patients), past headache (seven patients), and migraine on the maternal side of the family (10 patients). Among 11 patients who had a computed tomography scan, 10 were normal and one had an arachnoid cyst that was considered incidental.",
"   </p>",
"   <p>",
"    Some overlap exists between confusional migraine and the hemimigraine syndromes, transient global amnesia, Alice-in-Wonderland, and trauma-induced migraine. The differential diagnosis includes toxic or infectious encephalopathies and seizures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Menstrual migraine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Menstrual migraine (also called menstrually associated migraine or catamenial migraine) is defined as migraine headache that occurs in close temporal relationship to the onset of menstruation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/28\">",
"     28",
"    </a>",
"    ]; this time period usually encompasses two days before through three days after the onset of menstrual bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/5\">",
"     5",
"    </a>",
"    ]. Girls and women with menstrual migraine may also have migraine at other times during the month.",
"   </p>",
"   <p>",
"    The pathogenesis of menstrual migraine is thought to be related to the decrease in estrogen and progesterone levels that occur with menstruation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Menstrual migraine is usually not associated with aura even in women who have migraine with aura at other times [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although not all experts agree, there is some evidence that menstrual migraine attacks are longer, more severe, and more resistant to treatment than other migraine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. As an example, one observational study evaluated headache diary data from 155 women with migraine attending a headache clinic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/33\">",
"     33",
"    </a>",
"    ]. Migraine during the two days",
"    <strong>",
"     before",
"    </strong>",
"    menstruation was more likely to occur (RR 1.7; 95% CI 1.5-2.1) and was more likely to be severe (RR 2.1, 95% CI 1.3-3.3) than at other times of the month. Migraine during the first three days",
"    <strong>",
"     of",
"    </strong>",
"    menstruation was also more likely to occur (RR 2.5, 95% CI 2.2-2.8) and to be severe (RR 3.4, 95% CI 2.6-4.5). One potential weakness of this study is that data from a headache clinic population may not extrapolate to the general population of women with migraine.",
"   </p>",
"   <p>",
"    An earlier population-based headache diary study also found that attacks of migraine without aura were more likely to occur two days before onset of menses and on the first two days of menses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/35\">",
"     35",
"    </a>",
"    ]. However, headache intensity was reported to be only slightly greater for migraine during the first two days of menses, and this small difference was considered clinically unimportant.",
"   </p>",
"   <p>",
"    The treatment of menstrual migraine is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/3/18490?source=see_link&amp;anchor=H26#H26\">",
"     \"Management of migraine headache in children\", section on 'Menstrual migraine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Ophthalmoplegic migraine",
"    </span>",
"    &nbsp;&mdash;&nbsp;In ophthalmoplegic migraine, the headache is accompanied by oculomotor nerve dysfunction and blurred vision [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. However, the long headache duration (up to a week or more) and a long latent period (up to four days) before the onset of ophthalmoplegia that are characteristic features are atypical for migraine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/5\">",
"     5",
"    </a>",
"    ]. The third cranial nerve is most often involved, resulting in ptosis, pupillary dilation, exotropia, and diplopia. Sixth cranial nerve dysfunction (the second most common variant) leads to esotropia with inability to abduct the eye. Fourth cranial nerve involvement with vertical diplopia is rare.",
"   </p>",
"   <p>",
"    Thickening and enhancement the cisternal segment of the affected cranial nerve may be detected by MRI, suggesting the possibility that the etiology of ophthalmoplegic 'migraine' is a recurrent demyelinating neuropathy rather than migraine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. Due mainly to the MRI evidence of inflammation, ophthalmoplegic migraine has been reclassified as a cranial neuralgia in the revised IHS headache classification system published in 2004 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42327/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/9/33938?source=see_link\">",
"       \"Patient information: Migraine headaches in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/15/36086?source=see_link\">",
"       \"Patient information: Headache in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H173512940\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Migraine is the most common acute and recurrent headache syndrome in children. It is characterized by periodic episodes of paroxysmal headache accompanied by nausea, vomiting, abdominal pain, and relief with sleep. The current classification system from the International Headache Society (IHS) addresses migraine with and without aura and certain migraine syndromes unique to children. These syndromes &ndash; cyclical vomiting, abdominal migraine, benign paroxysmal vertigo of childhood &ndash; are considered \"childhood periodic syndromes that are commonly precursors of migraine.\" (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Historical aspects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In migraine without aura, patients typically have a prodrome consisting of pallor, an alteration in personality, or a change in appetite or thirst. The prodrome may precede the headache by several hours. Approximately 14 to 30 percent of children report an aura preceding a migraine. Auras represent progressive neurologic deficits or disturbances with subsequent complete recovery. Visual disturbances are the most common type, accounting for the majority of the neurologic symptoms associated with migraine. Auras may also involve other senses or occasionally cause motor or speech deficits. Some patients have several types of aura symptoms that vary with attacks. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Migraine without aura'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Migraine with aura'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The primary feature that separates hemiplegic migraine from other types of migraine with aura is the presence of motor weakness as a manifestation of aura in at least some attacks. Hemiplegic migraine may occur either in families or only in one individual (sporadic). Basilar-type migraine is a rare form of migraine with aura wherein the primary signs and symptoms are referable to either the brainstem or both cerebral hemispheres without weakness. (See",
"      <a class=\"local\" href=\"#H698850692\">",
"       'Hemiplegic migraine'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Basilar-type migraine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The childhood periodic syndromes are considered to be conditions that are commonly precursors of migraine. These include cyclical vomiting syndrome, abdominal migraine, and benign paroxysmal vertigo of childhood. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Childhood periodic syndromes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Retinal migraine is a rare disorder that is characterized by a sudden loss of vision or the perception of bright light (photopsia) or scintillations in one eye only, followed within one hour by a migrainous headache. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Retinal migraine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications of migraine include chronic migraine, status migrainosus, persistent aura without infarction, migrainous infarction, and migraine-triggered seizure. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Complications of migraine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other manifestations of migraine include the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Alice in Wonderland syndrome, characterized by headache that is preceded or accompanied by visual hallucinations, bizarre perceptual distortions (eg, of body image), or impairment of time sense. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Alice in Wonderland syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Confusional migraine, characterized by a headache that is typical of migraine associated with symptoms of agitation, disorientation, and aphasia that last longer than the headache. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Confusional migraine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Menstrual migraine is defined as migraine headache that occurs in close temporal relationship to the onset of menstruation. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Menstrual migraine'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      &ldquo;Ophthalmoplegic migraine&rdquo; is a cranial neuralgia that is characterized by headache accompanied by oculomotor nerve dysfunction and blurred vision. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Ophthalmoplegic migraine'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/1\">",
"      Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988; 8 Suppl 7:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/2\">",
"      Seshia SS, Wolstein JR, Adams C, et al. International headache society criteria and childhood headache. Dev Med Child Neurol 1994; 36:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/3\">",
"      Olesen J. International Headache Society classification and diagnostic criteria in children: a proposal for revision. Dev Med Child Neurol 1997; 39:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/4\">",
"      Winner P, Wasiewski W, Gladstein J, Linder S. Multicenter prospective evaluation of proposed pediatric migraine revisions to the IHS criteria. Pediatric Headache Committee of the American Association for the Study of Headache. Headache 1997; 37:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/5\">",
"      Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 Suppl 1:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/6\">",
"      Lipton RB, Bigal ME, Steiner TJ, et al. Classification of primary headaches. Neurology 2004; 63:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/7\">",
"      Hachinski VC, Porchawka J, Steele JC. Visual symptoms in the migraine syndrome. Neurology 1973; 23:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/8\">",
"      Cuvellier JC, L&eacute;pine A. Childhood periodic syndromes. Pediatr Neurol 2010; 42:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/9\">",
"      Fleisher DR, Matar M. The cyclic vomiting syndrome: a report of 71 cases and literature review. J Pediatr Gastroenterol Nutr 1993; 17:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/10\">",
"      Carson L, Lewis D, Tsou M, et al. Abdominal migraine: an under-diagnosed cause of recurrent abdominal pain in children. Headache 2011; 51:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/11\">",
"      Russell G, Abu-Arafeh I, Symon DN. Abdominal migraine: evidence for existence and treatment options. Paediatr Drugs 2002; 4:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/12\">",
"      Symon DN, Russell G. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine. Arch Dis Child 1995; 72:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/13\">",
"      Kakisaka Y, Wakusawa K, Haginoya K, et al. Efficacy of sumatriptan in two pediatric cases with abdominal pain-related functional gastrointestinal disorders: does the mechanism overlap that of migraine? J Child Neurol 2010; 25:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/14\">",
"      Tan V, Sahami AR, Peebles R, Shaw RJ. Abdominal migraine and treatment with intravenous valproic Acid. Psychosomatics 2006; 47:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/15\">",
"      Dignan F, Abu-Arafeh I, Russell G. The prognosis of childhood abdominal migraine. Arch Dis Child 2001; 84:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/16\">",
"      Herraiz C, Calvin FJ, Tapia MC, et al. The migraine: benign paroxysmal vertigo of childhood complex. Int Tinnitus J 1999; 5:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/17\">",
"      Fenichel GM. Migraine as a cause of benign paroxysmal vertigo of childhood. J Pediatr 1967; 71:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/18\">",
"      Russell G, Abu-Arafeh I. Paroxysmal vertigo in children--an epidemiological study. Int J Pediatr Otorhinolaryngol 1999; 49 Suppl 1:S105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/19\">",
"      Lanzi G, Balottin U, Fazzi E, et al. Benign paroxysmal vertigo of childhood: a long-term follow-up. Cephalalgia 1994; 14:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/20\">",
"      Carroll D. Retinal migraine. Headache 1970; 10:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/21\">",
"      Corbett JJ. Neuro-ophthalmic complications of migraine and cluster headaches. Neurol Clin 1983; 1:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/22\">",
"      Golden GS. The Alice in Wonderland syndrome in juvenile migraine. Pediatrics 1979; 63:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/23\">",
"      Ho CS, Shen EY, Liaw SB, Huang FY. Clinical observation and neurological outcomes in \"Alice in Wonderland\" syndrome. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1992; 33:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/24\">",
"      Evans RW, Rolak LA. The Alice in Wonderland Syndrome. Headache 2004; 44:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/25\">",
"      Liaw SB, Shen EY. Alice in Wonderland syndrome as a presenting symptom of EBV infection. Pediatr Neurol 1991; 7:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/26\">",
"      Ehyai A, Fenichel GM. The natural history of acute confusional migraine. Arch Neurol 1978; 35:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/27\">",
"      Shaabat A. Confusional migraine in childhood. Pediatr Neurol 1996; 15:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/28\">",
"      MacGregor EA. \"Menstrual\" migraine: towards a definition. Cephalalgia 1996; 16:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/29\">",
"      Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972; 22:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/30\">",
"      Silberstein SD, Merriam GR. Estrogens, progestins, and headache. Neurology 1991; 41:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/31\">",
"      Johannes CB, Linet MS, Stewart WF, et al. Relationship of headache to phase of the menstrual cycle among young women: a daily diary study. Neurology 1995; 45:1076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/32\">",
"      Visser WH, Jaspers NM, de Vriend RH, Ferrari MD. Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients. Cephalalgia 1996; 16:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/33\">",
"      MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004; 63:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/34\">",
"      Couturier EG, Bomhof MA, Neven AK, van Duijn NP. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003; 23:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/35\">",
"      Stewart WF, Lipton RB, Chee E, et al. Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000; 55:1517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/36\">",
"      Woody RC, Blaw ME. Ophthalmoplegic migraine in infancy. Clin Pediatr (Phila) 1986; 25:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/37\">",
"      Durkan GP, Troost BT, Slamovits TL, et al. Recurrent painless oculomotor palsy in children. A variant of ophthalmoplegic migraine? Headache 1981; 21:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/38\">",
"      Robertson WC Jr, Schnitzler ER. Ophthalmoplegic migraine in infancy. Pediatrics 1978; 61:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/39\">",
"      O'Hara MA, Anderson RT, Brown D. Magnetic resonance imaging in ophthalmoplegic migraine of children. J AAPOS 2001; 5:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/40\">",
"      Mark AS, Casselman J, Brown D, et al. Ophthalmoplegic migraine: reversible enhancement and thickening of the cisternal segment of the oculomotor nerve on contrast-enhanced MR images. AJNR Am J Neuroradiol 1998; 19:1887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42327/abstract/41\">",
"      Lance JW, Zagami AS. Ophthalmoplegic migraine: a recurrent demyelinating neuropathy? Cephalalgia 2001; 21:84.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6202 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-217.117.136.88-C2C11C53A9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42327=[""].join("\n");
var outline_f41_21_42327=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H173512940\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORICAL ASPECTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MIGRAINE WITHOUT AURA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MIGRAINE WITH AURA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Auras and prodrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Typical aura",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H698850692\">",
"      Hemiplegic migraine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Basilar-type migraine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CHILDHOOD PERIODIC SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cyclical vomiting syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Abdominal migraine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Benign paroxysmal vertigo of childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      RETINAL MIGRAINE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      COMPLICATIONS OF MIGRAINE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      MIGRAINE VARIANTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Alice in Wonderland syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Confusional migraine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Menstrual migraine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Ophthalmoplegic migraine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H173512940\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6202\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6202|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/31/11773\" title=\"table 1\">",
"      Diagnostic criteria migraine",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/44/44743?source=related_link\">",
"      Basilar-type migraine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/20/11593?source=related_link\">",
"      Causes of acute abdominal pain in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/48/34568?source=related_link\">",
"      Cyclic vomiting syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32953?source=related_link\">",
"      Headache, migraine, and stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/60/17354?source=related_link\">",
"      Hemiplegic migraine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/3/18490?source=related_link\">",
"      Management of migraine headache in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/25/8600?source=related_link\">",
"      Pathophysiology, clinical features, and diagnosis of migraine in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/15/36086?source=related_link\">",
"      Patient information: Headache in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/9/33938?source=related_link\">",
"      Patient information: Migraine headaches in children (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_21_42328="Carcinoma of the penis: Clinical presentation and diagnosis";
var content_f41_21_42328=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Carcinoma of the penis: Clinical presentation and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/21/42328/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/21/42328/contributors\">",
"     Curtis A Pettaway, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/21/42328/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/21/42328/contributors\">",
"     Jerome P Richie, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/21/42328/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/21/42328/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/21/42328/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H282022432\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cancers of the penis are rare in the United States, Europe, and other industrialized countries. However, the incidence of these malignancies is much higher in parts of South America, Africa, and Asia. The clinical presentation, pathologic features, diagnosis, and differential diagnosis of penile cancer are reviewed here. The epidemiology, staging, prognosis, and treatment for penile cancer are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/13/26840?source=see_link\">",
"     \"Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/4/41033?source=see_link\">",
"     \"Carcinoma of the penis: Surgical and medical treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022439\">",
"    <span class=\"h1\">",
"     ANATOMY OF THE PENIS AND REGIONAL NODES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Externally, the penis is composed of the head or the glans penis and the shaft. A cross section of the penile shaft is shown in the following (",
"    <a class=\"graphic graphic_figure graphicRef76391 \" href=\"mobipreview.htm?19/0/19462\">",
"     figure 1",
"    </a>",
"    ). It consists of the skin, subepithelial connective tissue, the erectile bodies (ie, corpora cavernosum), and the urethra (surrounded by the corpora spongiosum). The head of the penis (ie, penile glans) consists of an epithelial covering and the underlying dermis but is largely made up of a &ldquo;spongy&rdquo; expansion of the corpora spongiosum. At birth, the glans penis is covered by an extension of the shaft skin called the foreskin. Circumcision is a procedure that removes this foreskin at birth or later in life. At the tip of the glans is the urethral meatus, which allows for urination and ejection of semen. The proximal rounded surface of the glans penis is called the corona and serves as the junction between the glans (or head) and the penile shaft.",
"   </p>",
"   <p>",
"    Penile lymphatics drain both the glans penis and shaft and form an interconnecting network of channels. Drainage proceeds from the superficial inguinal lymph nodes to deep inguinal lymph nodes and then to external inguinal lymph nodes in the pelvis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022446\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Penile carcinoma almost always presents with a skin abnormality on or palpable lesion on the penis of a male patient with an average age of 50 years or older. However, penile cancer is not uncommon among younger men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/13/26840?source=see_link&amp;anchor=H282027080#H282027080\">",
"     \"Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a series of 243 men with newly diagnosed penile cancer, the most common signs were a painless lump (25 percent) or ulcer (13 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/2\">",
"     2",
"    </a>",
"    ]. Other signs included a rash (6 percent), bleeding (4 percent), or balanitis (4 percent). While inguinal adenopathy is present in 30 to 60 percent at diagnosis, malignant infiltration of the lymph nodes is demonstrated in only approximately half of these cases (range 47 to 85 percent) while adenopathy in the remainder likely represents an inflammatory reaction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/3\">",
"     3",
"    </a>",
"    ]. As such, the presence of palpable lymph nodes alone does not make the diagnosis of penile cancer more or less likely.",
"   </p>",
"   <p>",
"    Metastatic disease is uncommon until late in the disease course with only 1 to 10 percent of cases presenting with stage IV disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/4-9\">",
"     4-9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/13/26840?source=see_link&amp;anchor=H282027136#H282027136\">",
"     \"Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis\", section on 'Staging of penile cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022453\">",
"    <span class=\"h1\">",
"     PATHOLOGIC FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Squamous cell carcinoma (SCC) is the most common histology of penile cancer, accounting for 95 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/10\">",
"     10",
"    </a>",
"    ]. Nonsquamous histologies that may involve the penis include melanomas, basal cell carcinoma, lymphomas, and sarcomas. (See",
"    <a class=\"local\" href=\"#H282022588\">",
"     'Malignant lesions'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Penile SCC can be characterized and subclassified by microscopic histologic features into several subtypes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Usual tumors (48 to 65 percent) &mdash; These low grade lesions have little nuclear atypia and graduated keratinization. They are morphologically similar to other organ-specific SCC and can be nearly indistinguishable from normal epithelium.",
"     </li>",
"     <li>",
"      Papillary tumors (5 to 15 percent) &mdash; These tumors are low grade, but superficially invasive into erectile tissue. Microscopically they have evidence of both hyperkeratosis and papillomatosis. The lack of uniform papillae, absence of koilocytosis, and jagged stromal border distinguishes it from either verrucous or warty carcinoma. Papillary tumors are not associated with human papillomavirus (HPV) infection.",
"     </li>",
"     <li>",
"      Warty tumors (7 to 10 percent) &mdash; These are cauliflower-like cancers associated with HPV infection. The tumor is composed of a prominent fibrovascular core that exhibits papillomatous formations that penetrate the corpus cavernosum or spongiosum. The border with underlying stroma is jagged and irregular.",
"     </li>",
"     <li>",
"      Basaloid tumors (4 to 10 percent) &mdash; These are HPV-related cancers that present as an ulcerated irregular mass. They are comprised of uniform and small basaloid cells with central necrosis and are deeply invasive into the corpus cavernosum or spongiosum. Mitotic figures predominate and evidence of apoptosis is also seen microscopically.",
"     </li>",
"     <li>",
"      Verrucous tumors (3 to 8 percent) &mdash; These tumors are low grade and are associated with a broad pushing border instead of infiltrative growth. They are characterized by straight papillae lined by extremely well-differentiated neoplastic cells. There is hyperkeratosis on the surface with interpapillary keratin also present.",
"     </li>",
"     <li>",
"      Sarcomatoid tumors (less than 1 percent) &mdash; These are rare tumors of the penis that can be confused with malignant melanoma or sarcoma. They appear as deeply invasive ulcerated or rounded polypoid masses. Microscopically both squamous cell and spindle cell carcinoma components are seen. It may mimic features of heterologous sarcomas (eg, leiomyosarcoma, fibrosarcoma, and angiosarcoma).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Histology and tumor grade are important prognostic indicators for men with penile cancer. This is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/13/26840?source=see_link&amp;anchor=H282027164#H282027164\">",
"     \"Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022460\">",
"    <span class=\"h2\">",
"     Patterns of tumor infiltration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The manner in which squamous cell cancer infiltrates the normal tissue has been thought to reflect the tumor-host relationship. Although originally used to describe oral squamous cell carcinomas, the pattern of infiltration has been associated with the risk of nodal involvement in penile cancer. Two patterns are described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/12\">",
"     12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pushing infiltration &mdash; Blocks of tumor cells invade normal tissue but keep well defined boundaries separating it from normal tissue.",
"     </li>",
"     <li>",
"      Reticular infiltration &mdash; Smaller blocks of tumor cells broadly infiltrate the normal stroma.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022467\">",
"    <span class=\"h2\">",
"     Molecular alterations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several genetic pathways have been associated with the development of penile cancer, including p16 and p53 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The p16 gene encodes the protein p16INK4A, and increased expression of this protein has been seen as a late event following HPV infection and causes inactivation of the cell cycle cascade. In cervical carcinoma, increased expression of p16INK4A has been associated with malignant transformation in HPV-positive cancers. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/53/26455?source=see_link&amp;anchor=H11#H11\">",
"     \"Virology of human papillomavirus infections and the link to cancer\", section on 'Detecting hpv'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The tumor suppressor gene p53 encodes a transcription factor that normally blocks cell cycle progression. When altered (by deletion or mutation), it results in a loss of inhibition and results in malignant growth.",
"   </p>",
"   <p>",
"    Both p16 and p53 were evaluated in a retrospective study performed of 52 patients with newly diagnosed penile cancer that aimed to correlate findings with clinical outcomes. This study reported the following results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/13\">",
"     13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The protein p16INK4a was detected by immunohistochemistry (IHC) in 50 percent.",
"     </li>",
"     <li>",
"      Alterations in p16 gene regulation were common: 62 percent had loss of heterozygosity for p16INK4a and 42 percent showed hypermethylation of the promoter region.",
"     </li>",
"     <li>",
"      HPV DNA was detected in 32 percent.",
"     </li>",
"     <li>",
"      Nodal involvement was significantly associated with p16 negative IHC staining and alterations in p16 gene regulation.",
"     </li>",
"     <li>",
"      Loss of heterozygosity for p53 was seen in 42 percent, but this was not associated with clinical outcomes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These results implicate HPV in the progression of penile carcinoma and suggest a role for p16. However, further characterizations of the mechanisms involved are needed. Molecular testing does not play a role in the evaluation of penile cancer at this time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7028347\">",
"    <span class=\"h1\">",
"     EVALUATION OF SUSPECTED DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of penile cancer is suspected in uncircumcised men presenting with a penile mass or ulcer. The majority of cancers arises on the glans, in the coronal sulcus, or on the prepuce as either a mass or ulceration, and may be associated with a secondary infection. Our initial evaluation of a penile mass or ulcer depends upon whether the clinical presentation suggests the presence of infection or malignancy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If an infection appears to be present (eg, erythema, swelling, discharge), we prefer a four to six week course of antifungals or antibiotics, depending on the clinical exam. We reserve the use of steroids for patients with a confirmed diagnosis of an inflammatory lesion (ie, lichen sclerosus). Lesions that do not resolve after six weeks or that progress at any time should be biopsied.",
"     </li>",
"     <li>",
"      For men presenting with a penile lesion and lymphadenopathy, we suggest immediate biopsy of the penile lesion and if positive, inguinal ultrasound with fine needle aspiration of the involved lymph nodes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The presence of other physical signs (eg, hepatomegaly) or symptoms (eg, cachexia, confusion) may indicate the presence of metastatic disease or associated metabolic abnormalities such as hypercalcemia. Such patients also require a full laboratory evaluation as well as additional imaging as appropriate (eg, computed tomography scan or brain MRI) in addition to biopsy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/13/26840?source=see_link&amp;anchor=H282027157#H282027157\">",
"       \"Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis\", section on 'Assessment for distant metastatic (M) disease'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All patients require close follow-up to prevent an unnecessary delay in diagnosis. &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022474\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of penile cancer is made based upon the biopsy of the penile lesion interpreted within the clinical context. The American Joint Commission on Cancer allows for a biopsy using punch, incisional, or excisional techniques. Excisional biopsy is appropriate when the complete lesion can be removed and closed with little or no alteration to penile form and function. Otherwise, we perform incisional or deep punch biopsies for larger lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022481\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of the male patient presenting with a penile lesion includes premalignant, malignant, inflammatory and infectious etiologies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022488\">",
"    <span class=\"h2\">",
"     Inflammatory conditions",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Genital psoriasis",
"      </strong>",
"      &mdash; Psoriasis involves the genital area in 40 percent of affected individuals [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/18\">",
"       18",
"      </a>",
"      ]. The plaques are erythematous with sharply defined margins that are raised above the surrounding normal skin. Typical psoriatic scales may not be present due to the moisture in the genital area. These lesions are usually asymptomatic, although some patients complain of pruritus. Psoriasis is rarely isolated to the penis, however, and the presence of psoriatic scales elsewhere distinguishes it from penile cancer. Diagnosis and treatment of psoriasis is covered separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/62/27625?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of psoriasis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Angiokeratomas",
"      </strong>",
"      &mdash; Angiokeratomas are uncommon, benign, violaceous papules with overlying scale (",
"      <a class=\"external\" href=\"file:__www.uptodate.com_contents_image?imageKey=OBGYN_15579\">",
"       picture 27",
"      </a>",
"      ). They can present in both men and women, though they are more common in men. Penile angiokeratomas often occur on the glans penis, but can be found on the scrotum, thigh, and elsewhere. Typically, they are multiple and measure less than 1 cm in diameter [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/19\">",
"       19",
"      </a>",
"      ]. Both of these features are useful in distinguishing it from penile cancer, which is more commonly a single larger lesion. In most patients, the lesions are asymptomatic and do not require treatment; however, intermittent bleeding, pruritus, and pain can occur.",
"     </li>",
"     <li>",
"      <strong>",
"       Lichen planus",
"      </strong>",
"      &mdash; Lichen planus involving the penis is characterized by violaceous papules on the glans (",
"      <a class=\"external\" href=\"file:__www.uptodate.com_contents_image?imageKey=DERM_3565~DERM_28421\">",
"       picture 9A-B",
"      </a>",
"      ). Unlike penile cancer, lichen planus lesions are rarely asymptomatic. Most patients experience pruritus, which can be severe, and can become intensely painful if the lesions ulcerate or erode. The disease usually heals with significant postinflammatory hyperpigmentation. The diagnosis and treatment of lichen planus is detailed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9656?source=see_link&amp;anchor=H12#H12\">",
"       \"Lichen planus\", section on 'Genital lesions'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022496\">",
"    <span class=\"h2\">",
"     Infectious conditions",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Genital herpes",
"      </strong>",
"      &mdash; Genital herpes is caused by infection with herpes simplex virus (HSV1 or HSV2). The initial presentation can be severe with painful genital ulcers in association with other symptoms including systemic symptoms (eg, fever, headache, and malaise) and tender local inguinal lymphadenopathy. In contrast, penile cancer lesions are usually painless and not associated with systemic symptoms. A clinical diagnosis of genital herpes should be confirmed with laboratory testing. The topic of genital herpes is covered in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/10/9386?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Primary syphilis",
"      </strong>",
"      &mdash; Syphilis is a chronic infection caused by the bacterium Treponema pallidum. Primary syphilis can present with a painless papule on the penis. With time it ulcerates to produce the classic chancre of primary syphilis, a one to two centimeter ulcer with a raised, indurated margin. The ulcer generally has a non-exudative base and is associated with mild to moderate regional lymphadenopathy that is often bilateral. Multiple chancres can occur infrequently, particularly in the setting of HIV infection. Unlike penile cancer, chancres heal spontaneously within three to six weeks even in the absence of treatment. Since the ulcer is painless, many patients do not seek medical attention, a feature that enhances the likelihood of transmission. The topic of syphilis is covered in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/9/37017?source=see_link\">",
"       \"Pathogenesis, clinical manifestations, and treatment of early syphilis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022525\">",
"    <span class=\"h2\">",
"     Premalignant lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several penile lesions are recognized as premalignant, with the capacity to evolve into frankly invasive squamous cell carcinoma (SCC). These premalignant lesions are generally differentiated from SCC by biopsy. The extent to which premalignant lesions precede invasive penile carcinoma is unknown. The available evidence suggests that the majority of cases of penile SCC arises de novo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/20\">",
"     20",
"    </a>",
"    ]. As an example, in one series, only 39 of 511 men with penile cancer (8 percent) had a history of a previous or concomitant lesion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Condyloma acuminata",
"      </strong>",
"      &mdash; Condyloma acuminata, also known as genital or venereal warts, are soft, papillomatous growths that are associated with human papillomavirus (HPV) infection that can occur in the anogenital area of both men and women (",
"      <a class=\"graphic graphic_picture graphicRef74391 \" href=\"mobipreview.htm?14/18/14626\">",
"       picture 1",
"      </a>",
"      ). Although condylomata generally follow a benign course, malignant transformation has been noted, particularly in association with HPV subtypes 16, 18, 31, 33, 35, and 39 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/22,23\">",
"       22,23",
"      </a>",
"      ]. The increased incidence of penile carcinoma in men with condyloma acuminata was illustrated in a population based case-control study of 110 men with penile cancer and 355 control subjects, in which there was a six-fold increased risk of penile carcinoma in men reporting a history of genital warts compared to those without such a history [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/24\">",
"       24",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/38/23144?source=see_link\">",
"       \"Condylomata acuminata (anogenital warts)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/53/26455?source=see_link\">",
"       \"Virology of human papillomavirus infections and the link to cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Erythroplasia of Queyrat",
"      </strong>",
"      &mdash; Erythroplasia of Queyrat is a carcinoma in situ (CIS) arising within the penile mucocutaneous epithelium, namely the glans and prepuce (",
"      <a class=\"graphic graphic_picture graphicRef66886 \" href=\"mobipreview.htm?20/32/20996\">",
"       picture 2",
"      </a>",
"      ). It has a typical velvety red, well-marginated appearance. The lesions are usually solitary and occasionally erode or ulcerate, but pain is uncommon. In this regard, they may appear quite similar to penile carcinoma. Erythroplasia of Queyrat usually affects older, uncircumcised men. The reported incidence of progression to invasive carcinoma ranges from 10 to 33 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/25,26\">",
"       25,26",
"      </a>",
"      ]. The development of ulceration",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a papillary appearance are associated with disease progression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/26\">",
"       26",
"      </a>",
"      ]. An association with HPV 8 and 16 has been described [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Bowen's disease",
"      </strong>",
"      &mdash; Bowen's disease is a CIS occurring within follicle-bearing epithelium, such as on the penile shaft (",
"      <a class=\"graphic graphic_picture graphicRef61920 \" href=\"mobipreview.htm?39/50/40750\">",
"       picture 3",
"      </a>",
"      ). It usually appears as a solitary, dull-red plaque with areas of crusting and oozing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/25\">",
"       25",
"      </a>",
"      ]. In one series, HPV-16 was present in four of five biopsy specimens of genital Bowen's disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/28\">",
"       28",
"      </a>",
"      ]. If left untreated, SCC develops in approximately 5 percent of cases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Bowenoid papulosis",
"      </strong>",
"      &mdash; Bowenoid papulosis is another lesion that histologically resembles CIS. However it is most often seen in younger males and usually behaves in a benign fashion. It is characterized by multiple slightly elevated papules that are red to violet in color, which distinguishes this entity from penile carcinoma (",
"      <a class=\"graphic graphic_picture graphicRef76025 \" href=\"mobipreview.htm?18/50/19237\">",
"       picture 4",
"      </a>",
"      ). Lesions usually form on the penile shaft, although the glans and prepuce may also be affected [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/29,30\">",
"       29,30",
"      </a>",
"      ]. HPV has been implicated in the pathogenesis of Bowenoid papulosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/31-33\">",
"       31-33",
"      </a>",
"      ]. While the clinical course of Bowenoid papulosis is usually benign [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/34\">",
"       34",
"      </a>",
"      ], the disease has been known to progress to invasive SCC [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/32,33\">",
"       32,33",
"      </a>",
"      ]. Advanced age and immunosuppression may enhance the risk of malignant progression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Lichen sclerosis (LS) (aka, Balanitis xerotica obliterans)",
"      </strong>",
"      &mdash; LS is characterized by white atrophic plaques on the glans and prepuce (",
"      <a class=\"graphic graphic_picture graphicRef78530 \" href=\"mobipreview.htm?12/53/13138\">",
"       picture 5",
"      </a>",
"      ). These plaques eventually enlarge and coalesce into a sclerotic mass with resultant adhesions, phimosis, and meatal stenosis. Although many of the cases appear in men who have not undergone neonatal circumcision [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/36,37\">",
"       36,37",
"      </a>",
"      ], this is not always the case [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/38,39\">",
"       38,39",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/33/14872?source=see_link\">",
"       \"Balanitis and balanoposthitis in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Although generally considered benign, there is a relationship between balanitis xerotica obliterans and SCC in that the two may coexist, or LS may precede the later development of penile cancer:",
"     </li>",
"     <li>",
"      In one report of 86 men with genital lichen sclerosus (LS), premalignant or malignant histologic features developed in five cases, four of whom were HPV positive. The average lag time from onset of lichen sclerosus to the development of penile cancer was 17 years (range 10 to 23) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a second series of 130 men with genital LS, 11 had malignant or premalignant features (8.5 percent), including SCC in seven, verrucous carcinoma in two, SCC associated with verrucous carcinoma in one, and erythroplasia of Queyrat in one [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Leukoplakia",
"      </strong>",
"      &mdash; Chronic irritation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      inflammation are thought to be important in the pathogenesis of leukoplakia, a rare condition that typically presents as solitary or multiple white scaly plaques, often involving the meatus. Although the exact relationship to penile carcinoma is unknown, leukoplakia is often found adjacent or contiguous to areas of squamous cell carcinoma. The premalignant nature of leukoplakia is suggested by the presence of dysplasia in 10 to 20 percent of cases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/25,30\">",
"       25,30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Cutaneous horn",
"      </strong>",
"      &mdash; A penile cutaneous horn is an exophytic keratotic lesion formed by overgrowth and cornification of the epithelium. This appearance generally distinguishes it from penile carcinoma. Cutaneous horns typically form on the surface of preexisting lesions such as nevi, warts, or traumatic abrasions, and they are thought to represent a response to chronic preputial inflammation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/41\">",
"       41",
"      </a>",
"      ]. Malignant degeneration has been noted in cases of recurrent disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/42\">",
"       42",
"      </a>",
"      ]. Penile cutaneous horns may evolve into or form as a result of invasive carcinoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/43,44\">",
"       43,44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Pseudoepitheliomatous keratotic and micaceous balanitis (PKMB)",
"      </strong>",
"      &mdash; PKMB is an uncommon lesion that is named for its clinical appearance as a hyperkeratotic, laminated solitary plaque on the glans [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/45\">",
"       45",
"      </a>",
"      ]. PKMB often occurs in older men who are circumcised later in life. While the exact cause of PKMB remains unknown, malignant transformation into verrucous carcinoma has been reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/46-48\">",
"       46-48",
"      </a>",
"      ]. The hallmark of transformation is the development of a nodular exophytic lesion within the preexisting plaque. A biopsy is required to make this diagnosis and to rule out malignant transformation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022588\">",
"    <span class=\"h2\">",
"     Malignant lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;A biopsy is required to distinguish penile carcinoma from other malignancies that may present with penile lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022596\">",
"    <span class=\"h3\">",
"     Basal cell carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Basal cell carcinoma (BCC) is a common skin cancer arising from the basal layer of epidermis and its appendages. Although these tumors have a low metastatic potential, they are locally invasive and can be destructive of skin and the surrounding structures. Biopsy is essential to differentiate BCC from penile carcinoma. On biopsy, BCC is characterized by nests of basaloid cells that can exhibit a variety of growth patterns (eg,",
"    <span class=\"nowrap\">",
"     nodular/ulcerative,",
"    </span>",
"    diffuse, or superficial). Unlike squamous cell carcinoma, they are negative for EMA on immunohistochemistry, which can aid in the diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/39/14970?source=see_link&amp;anchor=H27#H27\">",
"     \"Epidemiology and clinical features of basal cell carcinoma\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022603\">",
"    <span class=\"h3\">",
"     Kaposi's sarcoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Kaposi&rsquo;s sarcoma (KS) is an angioproliferative disorder that requires infection with human herpesvirus-8 (HHV-8). Approximately 18 percent of patients with AIDS-related KS have penile lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/50\">",
"     50",
"    </a>",
"    ]. KS is characterized by the appearance of purplish, reddish blue or dark",
"    <span class=\"nowrap\">",
"     brown/black",
"    </span>",
"    macules, plaques, and nodules on the skin, which may ulcerate and bleed easily. The skin lesions range in size from very small to several centimeters in diameter, and they can remain unchanged for months to years, or grow rapidly within a few weeks and disseminate. The systemic nature of involvement with multiple nodules or skin discolorations involving areas beyond the penis distinguishes it from penile carcinoma. There may be accompanying lymphedema of the affected extremity, with or without bulky lymphadenopathy. Molecular analysis of KS lesions reveals amplified HHV-8 DNA sequences by polymerase chain reaction or HHV-8 latency-associated nuclear antigen (LANA-1) expression within spindle cells by immunohistochemical staining. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/8/38025?source=see_link\">",
"     \"Classic Kaposi's sarcoma: Clinical features, staging, diagnosis, and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022610\">",
"    <span class=\"h3\">",
"     Malignant melanoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Melanomas are the most aggressive form of skin cancer and can occur anywhere on the body. The following skin findings are suggestive of melanoma: a dark pigmented lesion with asymmetry, irregular borders, variegated color, diameter &gt;6 mm, or a recent change in a lesion. Unlike penile carcinoma, these are typically flat lesions without associated tumor. However, ulceration can occur in both diseases. Biopsy serves to establish the diagnosis with subsequent definitive excision based upon location and extent. Melanomas are characterized by neoplastic melanocytes found throughout the epidermal layers. Immunohistochemistry is useful in difficult cases or in nodal metastases. The most widely used markers to make a diagnosis of melanoma include S-100, MART-1, and HMB-45. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/20/16713?source=see_link&amp;anchor=H10884070#H10884070\">",
"     \"Skin examination and clinical features of melanoma\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022617\">",
"    <span class=\"h3\">",
"     Extramammary Paget's disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Paget&rsquo;s disease is an adenocarcinoma of apocrine gland-bearing skin that presents as a slowly expanding well-defined patch (white or erythematous) that is often pruritic (",
"    <a class=\"graphic graphic_picture graphicRef61775 \" href=\"mobipreview.htm?19/58/20391\">",
"     picture 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/51\">",
"     51",
"    </a>",
"    ]. The onset is typically insidious which helps to differentiate it from penile carcinoma. Paget&rsquo;s disease is characterized by Paget&rsquo;s cells, which are mucin positive and stain for low molecular weight cytokeratins (eg, CK7 and CK20), periodic acid-Schiff (PAS), and CEA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/52\">",
"     52",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022624\">",
"    <span class=\"h3\">",
"     Urethral carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary urethral cancer is a rare malignancy in men that arises commonly in the proximal segments of the urethra but can arise anywhere along the urethral length. Squamous cell carcinomas (SCCs) represent the predominant histology, with approximately 75 percent of male urethral cancers being SCCs, while 15 to 20 percent are transitional cell carcinomas, and 5 to 7 percent are adenocarcinomas. The most common symptom is urinary tract obstruction, which is not common in penile carcinoma. Other symptoms include hematuria (sometimes with blood dripping from the meatus), dysuria,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a purulent urethral discharge. When hematuria is present, it is more often seen on initiation rather than termination of the urinary stream. A biopsy of an intra-urethral lesion serves to establish the diagnosis and differentiate this from penile cancer, which occurs on the penile surface. Location may be the only factor that allows one to differentiate SCC histology as originating from the penis versus the urethra. The clinical presentation, diagnosis and evaluation of urethral carcinoma are covered separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/26/10664?source=see_link\">",
"     \"Urethral cancer in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022631\">",
"    <span class=\"h3\">",
"     Metastases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metastatic disease involving the penis is rare but is a poor prognostic indicator with median time to death of six months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/53\">",
"     53",
"    </a>",
"    ]. Penile metastases are generally a manifestation of wide-spread disease from another primary tumor site. Penile metastases often occur within the corpora cavernosa and are a cause of priapism. Biopsy of the lesion established the diagnosis. The poor prognosis of patients presenting with penile metastases was demonstrated in one series of 219 patients with penile metastases, over half had additional metastatic foci In one series of 219 patients with penile metastases, over half had additional metastatic foci [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42328/abstract/54\">",
"     54",
"    </a>",
"    ]. The primary cancer arose in the bladder (30 percent), prostate (30 percent), colon or rectum (16 percent), and kidney (11 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282022638\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Penile cancer almost always presents with a skin abnormality or palpable lesion in a male patient. It is most commonly seen in men 50 years or older but can occur in younger men. Lack of neonatal circumcision is a common associated finding. (See",
"      <a class=\"local\" href=\"#H282022446\">",
"       'Clinical presentation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/13/26840?source=see_link&amp;anchor=H282027080#H282027080\">",
"       \"Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis\", section on 'Epidemiology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The most common finding in men with penile cancer is a painless lump or ulcer on the penis. Although inguinal adenopathy is present in 30 to 60 percent, malignant infiltration of the lymph nodes is demonstrated in only approximately half of these cases. (See",
"      <a class=\"local\" href=\"#H282022446\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Primary squamous cell carcinoma (SCC) accounts for 95 percent of penile malignancies. The extent to which premalignant lesions precede invasive penile carcinoma is unknown. The available evidence suggests that the majority of cases of penile SCC arises de novo. (See",
"      <a class=\"local\" href=\"#H282022453\">",
"       'Pathologic features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Men presenting with a mass or ulceration involving the glans, coronal sulcus, or prepuce should be evaluated for penile cancer. If penile cancer is strongly considered, histologic evaluation is mandatory. (See",
"      <a class=\"local\" href=\"#H7028347\">",
"       'Evaluation of suspected disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For men with penile lesions that may be infectious in nature, a course of antifungals or antibiotics may be indicated. We reserve the use of steroids for patients with a confirmed diagnosis of an inflammatory lesion (ie, lichen sclerosus). Lesions that do not resolve after six weeks or that progress at any time should be biopsied. (See",
"      <a class=\"local\" href=\"#H7028347\">",
"       'Evaluation of suspected disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For men presenting with a penile lesion and lymphadenopathy, we suggest immediate biopsy of the penile lesion plus inguinal ultrasound with fine needle aspiration of the involved lymph nodes rather than a &ldquo;watch and see&rdquo; approach. (See",
"      <a class=\"local\" href=\"#H7028347\">",
"       'Evaluation of suspected disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The presence of other physical signs (eg, hepatomegaly) or symptoms (cachexia, confusion) may indicate the presence of metastatic disease and identify patients who require imaging (eg, computed tomography scan or brain MRI) and further laboratory evaluation in addition to biopsy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/13/26840?source=see_link&amp;anchor=H282027157#H282027157\">",
"       \"Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis\", section on 'Assessment for distant metastatic (M) disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The diagnosis of penile cancer is made based upon the biopsy of the penile lesion interpreted within the clinical context. We prefer an adequate deep biopsy (ie, incisional or deep punch) because it provides the most information to inform subsequent staging and treatment decisions. SCC is characterized and subclassified microscopically by the presence of keratinization and by cellular differentiation (tumor grade) into several subtypes. (See",
"      <a class=\"local\" href=\"#H282022474\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H282022453\">",
"       'Pathologic features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of the male patient presenting with a penile lesion includes premalignant, malignant, inflammatory and infectious etiologies. (See",
"      <a class=\"local\" href=\"#H282022481\">",
"       'Differential Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40891098\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The authors and editors would like to recognize Dr. Donald F Lynch, who contributed to previous versions of this topic review card.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/1\">",
"      Goodman MT, Hernandez BY, Shvetsov YB. Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995-2003. Cancer Epidemiol Biomarkers Prev 2007; 16:1833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/2\">",
"      Ritchie AW, Foster PW, Fowler S, BAUS Section of Oncology. Penile cancer in the UK: clinical presentation and outcome in 1998/99. BJU Int 2004; 94:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/3\">",
"      Heyns CF, Mendoza-Vald&eacute;s A, Pompeo AC. Diagnosis and staging of penile cancer. Urology 2010; 76:S15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/4\">",
"      BEGGS JH, SPRATT JS Jr. EPIDERMOID CARCINOMA OF THE PENIS. J Urol 1964; 91:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/5\">",
"      STAUBITZ WJ, LENT MH, OBERKIRCHER OJ. Carcinoma of the penis. Cancer 1955; 8:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/6\">",
"      RIVEROS M, GOROSTIAGA R. Cancer of the penis. Arch Surg 1962; 85:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/7\">",
"      Derrick FC Jr, Lynch KM Jr, Kretkowski RC, Yarbrough WJ. Epidermoid carcinoma of the penis: computer analysis of 87 cases. J Urol 1973; 110:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/8\">",
"      Johnson DE, Fuerst DE, Ayala AG. Carcinoma of the penis. Experience with 153 cases. Urology 1973; 1:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/9\">",
"      Kossow JH, Hotchkiss RS, Morales PA. Carcinoma of penis treated surgically. Analysis of 100 cases. Urology 1973; 2:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/10\">",
"      Burgers JK, Badalament RA, Drago JR. Penile cancer. Clinical presentation, diagnosis, and staging. Urol Clin North Am 1992; 19:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/11\">",
"      Calmon MF, Tasso Mota M, Vassallo J, Rahal P. Penile carcinoma: risk factors and molecular alterations. ScientificWorldJournal 2011; 11:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/12\">",
"      Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res 1987; 95:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/13\">",
"      Poetsch M, Hemmerich M, Kakies C, et al. Alterations in the tumor suppressor gene p16(INK4A) are associated with aggressive behavior of penile carcinomas. Virchows Arch 2011; 458:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/14\">",
"      Yanagawa N, Osakabe M, Hayashi M, et al. Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men. Pathol Int 2008; 58:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/15\">",
"      Delacroix SE Jr, Pettaway CA. Therapeutic strategies for advanced penile carcinoma. Curr Opin Support Palliat Care 2010; 4:285.",
"     </a>",
"    </li>",
"    <li>",
"     American Joint Committee on Cancer.. Penis.. In: American Joint Committee on Cancer, 7, Edge SB, Byrd DR, Compton CC.  (Eds), Springer, New York 2010. p.447.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/17\">",
"      Teichman JM, Sea J, Thompson IM, Elston DM. Noninfectious penile lesions. Am Fam Physician 2010; 81:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/18\">",
"      Buechner SA. Common skin disorders of the penis. BJU Int 2002; 90:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/19\">",
"      Leis-Dosil VM, Alijo-Serrano F, Aviles-Izquierdo JA, et al. Angiokeratoma of the glans penis: clinical, histopathological and dermoscopic correlation. Dermatol Online J 2007; 13:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/20\">",
"      Micali G, Innocenzi D, Nasca MR, et al. Squamous cell carcinoma of the penis. J Am Acad Dermatol 1996; 35:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/21\">",
"      Jensen MO. Cancer of the penis in Denmark 1942 to 1962 (511 cases). Dan Med Bull 1977; 24:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/22\">",
"      Boxer RJ, Skinner DG. Condylomata acuminata and squamous cell carcinoma. Urology 1977; 9:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/23\">",
"      Smotkin D. Virology of human papillomavirus. Clin Obstet Gynecol 1989; 32:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/24\">",
"      Maden C, Sherman KJ, Beckmann AM, et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst 1993; 85:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/25\">",
"      Mikhail GR. Cancers, precancers, and pseudocancers on the male genitalia. A review of clinical appearances, histopathology, and management. J Dermatol Surg Oncol 1980; 6:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/26\">",
"      Graham JH, Helwig EB. Erythroplasia of Queyrat. A clinicopathologic and histochemical study. Cancer 1973; 32:1396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/27\">",
"      Wieland U, Jurk S, Weissenborn S, et al. Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol 2000; 115:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/28\">",
"      Ikenberg H, Gissmann L, Gross G, et al. Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis. Int J Cancer 1983; 32:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/29\">",
"      Lucia MS, Miller GJ. Histopathology of malignant lesions of the penis. Urol Clin North Am 1992; 19:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/30\">",
"      Schellhammer PF, Jordan GH, Robey EL, Spaulding JT. Premalignant lesions and nonsquamous malignancy of the penis and carcinoma of the scrotum. Urol Clin North Am 1992; 19:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/31\">",
"      Gross G, Hagedorn M, Ikenberg H, et al. Bowenoid papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences. Arch Dermatol 1985; 121:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/32\">",
"      Bonnekoh B, Mahrle G, Steigleder GK. [Transition to cutaneous squamous cell carcinoma in 2 patients with bowenoid papulomatosis]. Z Hautkr 1987; 62:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/33\">",
"      Yoneta A, Yamashita T, Jin HY, et al. Development of squamous cell carcinoma by two high-risk human papillomaviruses (HPVs), a novel HPV-67 and HPV-31 from bowenoid papulosis. Br J Dermatol 2000; 143:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/34\">",
"      Patterson JW, Kao GF, Graham JH, Helwig EB. Bowenoid papulosis. A clinicopathologic study with ultrastructural observations. Cancer 1986; 57:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/35\">",
"      Schwartz RA, Janniger CK. Bowenoid papulosis. J Am Acad Dermatol 1991; 24:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/36\">",
"      Campus GV, Alia F, Bosincu L. Squamous cell carcinoma and lichen sclerosus et atrophicus of the prepuce. Plast Reconstr Surg 1992; 89:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/37\">",
"      Pride HB, Miller OF 3rd, Tyler WB. Penile squamous cell carcinoma arising from balanitis xerotica obliterans. J Am Acad Dermatol 1993; 29:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/38\">",
"      Barbagli G, Palminteri E, Mirri F, et al. Penile carcinoma in patients with genital lichen sclerosus: a multicenter survey. J Urol 2006; 175:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/39\">",
"      Depasquale I, Park AJ, Bracka A. The treatment of balanitis xerotica obliterans. BJU Int 2000; 86:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/40\">",
"      Nasca MR, Innocenzi D, Micali G. Penile cancer among patients with genital lichen sclerosus. J Am Acad Dermatol 1999; 41:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/41\">",
"      Lowe FC, McCullough AR. Cutaneous horns of the penis: an approach to management. Case report and review of the literature. J Am Acad Dermatol 1985; 13:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/42\">",
"      Fields T, Drylie D, Wilson J. Malignant evolution of penile horn. Urology 1987; 30:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/43\">",
"      PRESMAN D, ROLNICK D, TURBOW B. Penile horn. Am J Surg 1962; 104:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/44\">",
"      Hassan AA, Orteza AM, Milam DF. Penile horn: review of literature with 3 case reports. J Urol 1967; 97:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/45\">",
"      Bargman H. Pseudoepitheliomatous, keratotic, and micaceous balanitis. Cutis 1985; 35:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/46\">",
"      Beljaards RC, van Dijk E, Hausman R. Is pseudoepitheliomatous, micaceous and keratotic balanitis synonymous with verrucous carcinoma? Br J Dermatol 1987; 117:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/47\">",
"      Gray MR, Ansell ID. Pseudo-epitheliomatous hyperkeratotic and micaceous balanitis: evidence for regarding it as pre-malignant. Br J Urol 1990; 66:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/48\">",
"      Child FJ, Kim BK, Ganesan R, et al. Verrucous carcinoma arising in pseudoepitheliomatous keratotic and micaceous balanitis, without evidence of human papillomavirus. Br J Dermatol 2000; 143:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/49\">",
"      Fan YS, Carr RA, Sanders DS, et al. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma. Histopathology 2007; 51:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/50\">",
"      Grossman HB. Premalignant and early carcinomas of the penis and scrotum. Urol Clin North Am 1992; 19:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/51\">",
"      Anolik R, Liang C, Wang N, et al. Extramammary Paget disease. Dermatol Online J 2008; 14:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/52\">",
"      Kim SA, Kwon JI, Jung HR, et al. Primary Extramammary Paget's Disease Combined with Bowen's Disease in Vulva. Ann Dermatol 2011; 23:S222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/53\">",
"      Chaux A, Amin M, Cubilla AL, Young RH. Metastatic tumors to the penis: a report of 17 cases and review of the literature. Int J Surg Pathol 2011; 19:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42328/abstract/54\">",
"      Powell BL, Craig JB, Muss HB. Secondary malignancies of the penis and epididymis: a case report and review of the literature. J Clin Oncol 1985; 3:110.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2959 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-189.2.19.178-DF24B1B659-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42328=[""].join("\n");
var outline_f41_21_42328=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H282022638\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282022432\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282022439\">",
"      ANATOMY OF THE PENIS AND REGIONAL NODES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282022446\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282022453\">",
"      PATHOLOGIC FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H282022460\">",
"      Patterns of tumor infiltration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H282022467\">",
"      Molecular alterations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7028347\">",
"      EVALUATION OF SUSPECTED DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282022474\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282022481\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H282022488\">",
"      Inflammatory conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H282022496\">",
"      Infectious conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H282022525\">",
"      Premalignant lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H282022588\">",
"      Malignant lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H282022596\">",
"      - Basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H282022603\">",
"      - Kaposi's sarcoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H282022610\">",
"      - Malignant melanoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H282022617\">",
"      - Extramammary Paget's disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H282022624\">",
"      - Urethral carcinoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H282022631\">",
"      - Metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282022638\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40891098\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2959\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2959|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/0/19462\" title=\"figure 1\">",
"      Penis anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2959|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?14/18/14626\" title=\"picture 1\">",
"      Condyloma acuminata",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?20/32/20996\" title=\"picture 2\">",
"      Erythroplasia of Queyrat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/50/40750\" title=\"picture 3\">",
"      Bowens disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/50/19237\" title=\"picture 4\">",
"      Bowenoid papulosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?12/53/13138\" title=\"picture 5\">",
"      Balanitis xerotica obliterans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?19/58/20391\" title=\"picture 6\">",
"      Pagets vulva",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/33/14872?source=related_link\">",
"      Balanitis and balanoposthitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/13/26840?source=related_link\">",
"      Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/4/41033?source=related_link\">",
"      Carcinoma of the penis: Surgical and medical treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/8/38025?source=related_link\">",
"      Classic Kaposi's sarcoma: Clinical features, staging, diagnosis, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/38/23144?source=related_link\">",
"      Condylomata acuminata (anogenital warts)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/39/14970?source=related_link\">",
"      Epidemiology and clinical features of basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/10/9386?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/62/27625?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9656?source=related_link\">",
"      Lichen planus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/9/37017?source=related_link\">",
"      Pathogenesis, clinical manifestations, and treatment of early syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/20/16713?source=related_link\">",
"      Skin examination and clinical features of melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/26/10664?source=related_link\">",
"      Urethral cancer in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/53/26455?source=related_link\">",
"      Virology of human papillomavirus infections and the link to cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_21_42329="Systemic treatment for unresectable malignant pleural mesothelioma";
var content_f41_21_42329=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Systemic treatment for unresectable malignant pleural mesothelioma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/21/42329/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/21/42329/contributors\">",
"     Anne S Tsao, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/21/42329/contributors\">",
"     Nicholas Vogelzang, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/21/42329/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/21/42329/contributors\">",
"     Arthur T Skarin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/21/42329/contributors\">",
"     Rogerio C Lilenbaum, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/21/42329/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/21/42329/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/21/42329/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant mesothelioma is a rare neoplasm that arises most commonly from the mesothelial surfaces of the pleural cavity, less commonly from the peritoneal surface, and extremely rarely from the tunica vaginalis or pericardium. It has an extremely poor prognosis; the median survival is 4 to 13 months for untreated patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/1\">",
"     1",
"    </a>",
"    ] and 6 to 18 months for treated patients, regardless of the therapeutic approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The systemic treatment of unresectable malignant pleural mesothelioma (MPM) will be reviewed here, while the application of chemotherapy as a component of a combined modality approach that includes definitive surgery is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/41/28312?source=see_link\">",
"     \"Treatment approaches for localized malignant pleural mesothelioma and solitary fibrous tumor of the pleura\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other related topics include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/50/32552?source=see_link\">",
"       \"Clinical presentation, diagnosis, and staging of malignant pleural mesothelioma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/33/29204?source=see_link\">",
"       \"Pathology of malignant pleural mesothelioma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/28/7622?source=see_link\">",
"       \"Epidemiology of malignant mesothelioma\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1937732754\">",
"    <span class=\"h1\">",
"     INITIAL EVALUATION AND CLINICAL APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with MPM present with the gradual onset of pulmonary symptoms (dyspnea, cough, chest pain). Symptoms generally lead to a diagnosis when extensive intrathoracic disease is present. (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/50/32552?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical presentation, diagnosis, and staging of malignant pleural mesothelioma\", section on 'Clinical manifestations'",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1937732761\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typical findings on chest imaging combined with a history of asbestos exposure may raise the suspicion of a MPM. The diagnosis of MPM requires an adequate tissue sample from the tumor. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/50/32552?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical presentation, diagnosis, and staging of malignant pleural mesothelioma\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/33/29204?source=see_link\">",
"     \"Pathology of malignant pleural mesothelioma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most widely used staging system is the tumor (T), node (N), metastasis (M) staging system that is used by the International Union Against Cancer (UICC) and the American Joint Committee on Cancer (AJCC) (",
"    <a class=\"graphic graphic_table graphicRef81665 \" href=\"mobipreview.htm?43/19/44349\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/4\">",
"     4",
"    </a>",
"    ]. (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/50/32552?source=see_link&amp;anchor=H16615464#H16615464\">",
"     \"Clinical presentation, diagnosis, and staging of malignant pleural mesothelioma\", section on 'Staging'",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1937732775\">",
"    <span class=\"h2\">",
"     Clinical approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;A multidisciplinary treatment plan is based upon the assessment of the extent of disease, the patient&rsquo;s overall condition including cardiopulmonary function and other comorbidity, and their desire for aggressive treatment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/41/28312?source=see_link\">",
"     \"Treatment approaches for localized malignant pleural mesothelioma and solitary fibrous tumor of the pleura\"",
"    </a>",
"    .):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Surgical candidates",
"      </strong>",
"      : For patients who have surgically resectable disease limited to one hemithorax and have no medical contraindication to surgery, we use a combined modality approach that incorporates surgery aimed at a maximal complete resection with chemotherapy and radiation therapy (RT). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/41/28312?source=see_link\">",
"       \"Treatment approaches for localized malignant pleural mesothelioma and solitary fibrous tumor of the pleura\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Non surgical candidates",
"      </strong>",
"      : For patients who have disease in which an MCR is not feasible and for those who are not candidates for definitive surgery because of age, inadequate cardiopulmonary reserve, or other comorbidity, systemic chemotherapy and symptom directed treatment may be beneficial. (See",
"      <a class=\"local\" href=\"#H1937732919\">",
"       'Combination chemotherapy'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    After the initial evaluation for possible resection, approximately 80 percent of patients with pleural MPM will not be candidates for combined modality approach that includes definitive surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3402924\">",
"    <span class=\"h2\">",
"     Prognostic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various studies have looked at different clinical and pathologic parameters in order to identify patients with particularly good or poor prognoses.",
"   </p>",
"   <p>",
"    The Cancer and Leukemia Group B (CALGB) and the European Organization for Research and Treatment of Cancer (EORTC) have identified key clinical prognostic factors (",
"    <a class=\"graphic graphic_table graphicRef73700 \" href=\"mobipreview.htm?35/54/36717\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74894 \" href=\"mobipreview.htm?20/7/20605\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. In all the large surgical trials done to date, histology has had a significant impact on prognosis, with sarcomatoid and biphasic subtypes having worse outcomes compared to epithelioid mesothelioma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/50/32552?source=see_link&amp;anchor=H16617048#H16617048\">",
"     \"Clinical presentation, diagnosis, and staging of malignant pleural mesothelioma\", section on 'Prognostic scoring systems'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The small number of mesothelioma patients enrolled in clinical trials and the heterogeneity of study populations has limited the identification of molecular biomarkers for prognosis. New molecular technologies, such as gene expression profiling, may eventually classify patients into distinct prognostic subgroups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3402931\">",
"    <span class=\"h2\">",
"     Response assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several ways to assess clinical benefit: response rate, disease control rate, progression-free survival, and overall survival. Overall survival has been the primary endpoint in contemporary randomized trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both the objective response rate and progression-free survival have been used as surrogates for efficacy in older studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/11\">",
"     11",
"    </a>",
"    ]. In malignant pleural mesothelioma studies, there are two radiographic measurement systems that are employed using thoracic CT scans: RECIST and modified RECIST (",
"    <a class=\"graphic graphic_table graphicRef74693 \" href=\"mobipreview.htm?41/48/42764\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Modified RECIST measures the pleural rind or tumor thickness in a perpendicular manner to the chest wall in two positions at three separate levels on a chest CT scan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other imaging modalities are under investigation for use in mesothelioma tumor measurements. Positron emission tomography combined with CT scanning",
"    <span class=\"nowrap\">",
"     (PET/CT)",
"    </span>",
"    can detect a decrease in metabolic activity in the tumor and may be a better predictor of time to progression rather than objective response as determined by computed tomography alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/15\">",
"     15",
"    </a>",
"    ]. However the",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    endpoint has not been validated in phase III trials.",
"   </p>",
"   <p>",
"    Measurement of serum levels of soluble mesothelin-related peptide (SMRP) may be useful in detecting recurrence of disease after surgical resection. It is less clear whether it can assess response to systemic therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/16\">",
"     16",
"    </a>",
"    ]. This approach has been shown to correlate with the radiologic assessment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/50/32552?source=see_link&amp;anchor=H1568139510#H1568139510\">",
"     \"Clinical presentation, diagnosis, and staging of malignant pleural mesothelioma\", section on 'Mesothelin'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1937732919\">",
"    <span class=\"h1\">",
"     COMBINATION CHEMOTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combination chemotherapy using the regimen of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    has become the standard of care, based upon a phase III trial that demonstrate a prolongation of overall survival compared to treatment with cisplatin alone. Other platinum based regimens may also be as effective but have not been studied as extensively.",
"   </p>",
"   <p>",
"    The only randomized trial that directly compared chemotherapy (single agent",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/59/953?source=see_link\">",
"     vinorelbine",
"    </a>",
"    or a combination of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/16/38144?source=see_link\">",
"     mitomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/3/4152?source=see_link\">",
"     vinblastine",
"    </a>",
"    , and low-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    ) to active supportive was terminated prematurely due to poor accrual [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/17\">",
"     17",
"    </a>",
"    ]. That trial failed to demonstrate a statistically significant improvement in overall survival. However, subsequent trials using contemporary cisplatin-based doublets have demonstrated a significant prolongation in overall survival compared with single agent cisplatin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1937732994\">",
"    <span class=\"h2\">",
"     Pemetrexed plus cisplatin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The combination of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    , incorporating prophylactic",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    and vitamin B12, is the standard of care for patients with malignant pleural mesothelioma whose disease is either unresectable or who are not otherwise candidates for potentially curative surgery. The role of maintenance pemetrexed after completion of four to six cycles of the platinum-based doublet remains uncertain.",
"   </p>",
"   <p>",
"    In the single-blinded EMPHACIS trial, 456 patients were randomly assigned to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    (75",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    plus either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    (500",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    or placebo, both given once every three weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/18\">",
"     18",
"    </a>",
"    ]. The median survival was significantly longer for the combination (12.1 versus 9.3 months), as was the time to progression (5.7 versus 3.9 months) and the objective response rate (41 versus 17 percent).",
"   </p>",
"   <p>",
"    Differences in survival were most striking in patients who received supplementation with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    and vitamin B12 during therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/18\">",
"     18",
"    </a>",
"    ]. Furthermore, treatment-related toxicity was significantly less, and the mean number of administered cycles of therapy (both single agent",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    as well as the combination) was significantly greater in supplemented compared to nonsupplemented patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a multivariate regression analysis of prognostic factors derived from this trial, factors predictive of longer overall survival were therapy group, vitamin supplementation group, Karnofsky performance status (90-100 versus 70-80, (",
"    <a class=\"graphic graphic_table graphicRef58785 \" href=\"mobipreview.htm?2/11/2236\">",
"     table 5",
"    </a>",
"    )), disease stage, histologic subtype, and white blood cell count",
"    <span class=\"nowrap\">",
"     (&ge;8200/microL",
"    </span>",
"    versus lower values) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are no standard assays for predictive biomarkers that are currently recommended. However, a retrospective study of 60 malignant pleural mesothelioma patients correlated low thymidylate synthase levels with improved time to progression and overall survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/21\">",
"     21",
"    </a>",
"    ]. Prospective trials to evaluate thymidylate synthase as a predictive biomarker for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    therapy are ongoing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1937733683\">",
"    <span class=\"h2\">",
"     Pemetrexed plus carboplatin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38873?source=see_link\">",
"     Carboplatin",
"    </a>",
"    has been substituted for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    in conjunction with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    in an effort to decrease toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/22-24\">",
"     22-24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the larger of two nonrandomized phase II studies, 102 patients were treated every 21 days with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    (AUC 5) plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    (500",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"     ),",
"    </span>",
"    with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    and vitamin B12 supplementation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/22\">",
"     22",
"    </a>",
"    ]. Objective responses were observed in 19 percent, with a median time to progression of 6.5 months and a median survival of 12.7 months. A secondary analysis of two of these trials based upon patient age found that the carboplatin plus pemetrexed regimen was well tolerated and had a similar level of activity in those &ge;70 years, compared to those who were younger [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These results are similar to those with the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    -based combination, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    may be an alternative regimen if cisplatin toxicity is a particular concern.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1937733690\">",
"    <span class=\"h2\">",
"     Raltitrexed plus cisplatin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The combination of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/1/21525?source=see_link\">",
"     raltitrexed",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    prolongs survival compared to cisplatin alone in patients with previously untreated advanced mesothelioma.",
"   </p>",
"   <p>",
"    This was illustrated in a phase III trial in which 250 patients were randomly assigned to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/1/21525?source=see_link\">",
"     raltitrexed",
"    </a>",
"    (3",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    (80",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"     ,",
"    </span>",
"    both in 21 day cycles) or the same dose of cisplatin alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Overall survival in all randomized patients was significantly increased with the combination regimen: the median survival was 11.4 versus 8.8 months with single agent",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      and the one-year survival was 46 versus 40 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the 213 patients with measurable disease, the combined therapy group had a higher objective response rate (24 versus 14 percent, p = 0.06) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A separate analysis of health-related quality of life (QOL) showed that overall QOL was impaired at baseline but was stable for those remaining on treatment with both regimens [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/27\">",
"       27",
"      </a>",
"      ]. Dyspnea improved with treatment, an effect that was statistically significant for the two-drug regimen.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/1/21525?source=see_link\">",
"     Raltitrexed",
"    </a>",
"    is not commercially available in the United States.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3402373\">",
"    <span class=\"h2\">",
"     Gemcitabine plus cisplatin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/1/31769?source=see_link\">",
"     Gemcitabine",
"    </a>",
"    has been combined with platinum compounds, including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/28-32\">",
"     28-32",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/33\">",
"     33",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/34\">",
"     34",
"    </a>",
"    ]. Response rates for these combinations have ranged from 15 to 48 percent, with acceptable levels of toxicity.",
"    <br/>",
"    <br/>",
"    The potential value of the gemcitabine plus cisplatin regimen was illustrated by a multicenter phase II trial, in which 106 previously untreated patients were treated with gemcitabine plus cisplatin and randomly assigned to receive either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/20/2377?source=see_link\">",
"     bevacizumab",
"    </a>",
"    or placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/32\">",
"     32",
"    </a>",
"    ]. The median survival was approximately 15 months on both treatment arms, consistent with the results seen with cisplatin plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3402445\">",
"    <span class=\"h2\">",
"     Other regimens",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     Cisplatin",
"    </a>",
"    has also been combined with a number of older chemotherapy agents in phase II studies. These include anthracyclines (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/27/4536?source=see_link\">",
"     epirubicin",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/35-38\">",
"     35-38",
"    </a>",
"    ], the combination of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/16/38144?source=see_link\">",
"     mitomycin",
"    </a>",
"    , plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/35-37\">",
"     35-37",
"    </a>",
"    ], and the combination of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/3/4152?source=see_link\">",
"     vinblastine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    The results from these studies do not suggest any advantage compared to combinations of cisplatin plus either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/1/31769?source=see_link\">",
"     gemcitabine",
"    </a>",
"    and in fact may be somewhat inferior [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/17,40\">",
"     17,40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SINGLE AGENT CHEMOTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phase II studies have found clinical activity, as evidenced by response rates, for a number of agents. Although single agent chemotherapy has not been shown to prolong survival in previously untreated patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/10\">",
"     10",
"    </a>",
"    ], these agents have a role as second-line therapy in some patients.",
"   </p>",
"   <p>",
"    Agents that have shown substantial activity in phase II include the following:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3402150\">",
"    <span class=\"h2\">",
"     Platinum compounds",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a meta-analysis of virtually all phase II trials published through 2001,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    was the most active single agent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/41\">",
"     41",
"    </a>",
"    ]. Cisplatin has thus become the backbone for combination chemotherapy regimens.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38873?source=see_link\">",
"     Carboplatin",
"    </a>",
"    may also have activity although the data are much less extensive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/42,43\">",
"     42,43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3402035\">",
"    <span class=\"h2\">",
"     Pemetrexed",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most extensive data in the second-line setting are for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    , either alone or in combination with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/44-49\">",
"     44-49",
"    </a>",
"    ]. Other drugs that have been used include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/1/31769?source=see_link\">",
"     gemcitabine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/59/953?source=see_link\">",
"     vinorelbine",
"    </a>",
"    , and anthracyclines. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Single agent chemotherapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    An analysis of the phase III EMPHACIS trial of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    versus cisplatin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/18\">",
"     18",
"    </a>",
"    ] identified second-line (post-study) chemotherapy as a significant predictor of extended survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/49\">",
"     49",
"    </a>",
"    ]. A survival benefit from chemotherapy was suggested by a retrospective multiple regression analysis of patient risk factors. (See",
"    <a class=\"local\" href=\"#H1937732994\">",
"     'Pemetrexed plus cisplatin'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Additional information about the role of second-line chemotherapy comes from a multicenter trial, in which 243 previously treated patients were randomly assigned to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    or best supportive care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/48\">",
"     48",
"    </a>",
"    ]. Pemetrexed significantly increased the median progression-free survival, time to progression, and time to treatment failure (3.6 versus 1.5, 3.7 versus 1.5, and 3.6 versus 1.5 months, respectively).",
"   </p>",
"   <p>",
"    However,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    did not improve median survival (8.4 versus 9.7 months with best supportive care). An overall survival benefit may have been obscured, since 52 percent of those assigned to best supportive care received systemic chemotherapy once disease progression was evident. Other antifolates with single agent activity include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/50\">",
"     50",
"    </a>",
"    ], edatrexate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/51\">",
"     51",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/1/21525?source=see_link\">",
"     raltitrexed",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3402298\">",
"    <span class=\"h2\">",
"     Other agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several other agents have also demonstrated activity in phase II studies, based upon rates of objective tumor regression. These may be useful as second line therapy when they were not part of the original chemotherapy regimen. Such agents include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/1/31769?source=see_link\">",
"     gemcitabine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/53,54\">",
"     53,54",
"    </a>",
"    ], anthracyclines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/55-57\">",
"     55-57",
"    </a>",
"    ], and vinca alkaloids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/58,59\">",
"     58,59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     EXPERIMENTAL APPROACHES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of nonchemotherapy-based systemic treatments for mesothelioma has rapidly expanded since the mid-1990s. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Molecularly targeted therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Molecularly targeted agents targeted are being evaluated for their activity in patients with advanced mesothelioma. Additional clinical trials are required to establish whether these approaches will have a role in patient management.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epidermal growth factor receptor (EGFR) pathway &mdash; EGFR is overexpressed in most malignant mesotheliomas. In one phase II study, 43 patients were treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/12/19654?source=see_link\">",
"       gefitinib",
"      </a>",
"      , with two objective responses [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/60\">",
"       60",
"      </a>",
"      ]. In another phase II study, 63 previously untreated patients were given",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/13/36056?source=see_link\">",
"       erlotinib",
"      </a>",
"      ; no objective responses were observed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Angiogenesis inhibitors &mdash; Vascular endothelial growth factor (VEGF) pathway and platelet derived growth factor (PDGF) receptor pathways have been targeted in mesothelioma. Both tyrosine kinase inhibitors (TKIs) and monoclonal antibodies has been studied:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/45/9944?source=see_link\">",
"       Sorafenib",
"      </a>",
"      , VEGF TK inhibitor, has some activity. In a preliminary report of a phase II study, partial responses were observed in 3 of 23 previously treated patients (23 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/62\">",
"       62",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/20/2377?source=see_link\">",
"       Bevacizumab",
"      </a>",
"      , a monoclonal antibody that binds VEGF, was combined with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/1/31769?source=see_link\">",
"       gemcitabine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      in a randomized phase II trial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/63\">",
"       63",
"      </a>",
"      ]. The addition of bevacizumab did not improve overall survival compared to chemotherapy alone.",
"     </li>",
"     <li>",
"      Cediranib (a VEGF receptor and PDGF receptor TKI) is under investigation as monotherapy in the salvage setting (SWOG 0509) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/64\">",
"       64",
"      </a>",
"      ] and in chemona&iuml;ve patients in combination with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      -",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"       pemetrexed",
"      </a>",
"      (SWOG 0905, NCT01064648) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/65\">",
"       65",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/1/17434?source=see_link\">",
"       Imatinib",
"      </a>",
"      mesylate (a c-Kit, bcr-abl, PDGF receptor TKI) as monotherapy has minimal efficacy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/66-68\">",
"       66-68",
"      </a>",
"      ]. Studies combining imatinib with chemotherapy are ongoing.",
"     </li>",
"     <li>",
"      Vatalanib (a VEGF receptor, PDGF receptor, and c-Kit TKI) gave an 11 percent response rate and median overall survival of 10 months in a phase II trial of 47 patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/69\">",
"       69",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/62/29673?source=see_link\">",
"       Thalidomide",
"      </a>",
"      (a VEGF, TNF-alpha, beta fibroblast growth factor [bFGF] inhibitor) as monotherapy and in combination with chemotherapy yielded a 28 percent disease control rate at six months but an overall survival of only seven months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/70,71\">",
"       70,71",
"      </a>",
"      ]. Use of thalidomide as maintenance therapy following cytotoxic chemotherapy showed no evidence of improvement in either progression-free survival or overall survival [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/72\">",
"       72",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?43/10/44200?source=see_link\">",
"       Sunitinib",
"      </a>",
"      (a VEGF receptor and PDGF receptor TKI) yielded a 15 percent response rate and six month median overall survival in a phase II trial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/62\">",
"       62",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Histone deacetylase inhibition &mdash; Preliminary evidence from a phase I trial suggested that",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/29/27093?source=see_link\">",
"       vorinostat",
"      </a>",
"      might have clinically meaningful activity in patients with mesothelioma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/73\">",
"       73",
"      </a>",
"      ]. However, a phase III trial (Vantage 014) that compared vorinostat with placebo in 660 pretreated mesothelioma patients who had progressed on one or two prior therapies failed to demonstrate a significant improvement in overall survival [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/74\">",
"       74",
"      </a>",
"      ]. Vorinostat (300 mg twice daily) or placebo was given for three days each week of a 21-day cycle. Although the median progression-free survival for vorinostat was 6.3 weeks compared to 6.1 weeks (HR 0.75, p&lt;0.001), this did not translate into a statistically significant overall survival benefit for vorinostat compared with placebo (median 30.7 versus 27.1 weeks [HR 0.98, p = 0.858]). &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Immunotherapy and gene therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunotherapy with systemically administered interleukin (IL)-2 has limited efficacy and substantial adverse effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/75,76\">",
"     75,76",
"    </a>",
"    ]. In a study of 29 patients with advanced mesothelioma who received recombinant IL-2 as a single agent, there were only two partial responses (objective response rate, 8 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/75\">",
"     75",
"    </a>",
"    ]. Nevertheless, further studies of systemic IL-2, as well as artificial upregulation of endogenous IL-2 by gene transfer are underway, based upon data from murine models of mesothelioma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/77\">",
"     77",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    More promising results have been reported for intrapleural or intratumoral administration of IL-2; these approaches and others involving gene therapy are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/41/28312?source=see_link\">",
"     \"Treatment approaches for localized malignant pleural mesothelioma and solitary fibrous tumor of the pleura\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One of the most attractive targets for therapy is mesothelin, a tumor differentiation antigen that is overexpressed by most epithelial mesotheliomas but not by normal cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/78,79\">",
"     78,79",
"    </a>",
"    ]. Three mesothelin-targeted agents are in various stages of clinical development. These include SS1P (anti-mesothelin dsFv-PE38), a recombinant immunotoxin composed of an anti-mesothelin Fv fragment linked to a truncated Pseudomonas exotoxin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/80-82\">",
"     80-82",
"    </a>",
"    ], MORAb-009, a chimeric anti-mesothelin monoclonal antibody [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/83\">",
"     83",
"    </a>",
"    ], and CRS-207, a live-attenuated Listeria monocytogenes vector encoding human mesothelin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/84\">",
"     84",
"    </a>",
"    ]. The rationale for mesothelin as a tumor vaccine is that mesothelin elicits a strong T-cell response in patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/85\">",
"     85",
"    </a>",
"    ]. Phase I trials have been completed with SS1P and MORab-009, and some evidence of minor antitumor activity has been observed with SS1P [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/81\">",
"     81",
"    </a>",
"    ]. Preclinical models suggest significant synergy between these agents and systemic chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/86,87\">",
"     86,87",
"    </a>",
"    ], and trials of combined therapy are underway.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Chemoimmunotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chemoimmunotherapy is only rarely used since the approval of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    . Interferon-alfa 2a and interferon-gamma 1b have been combined with various standard chemotherapies for mesothelioma. The response rates in these trials have been variable (for interferon-alfa 2b plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    , 27 to 36 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/88\">",
"     88",
"    </a>",
"    ]; for interferon-alfa 2b with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    alone, 11 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/89\">",
"     89",
"    </a>",
"    ]; and for interferon-alfa 2b with cisplatin plus doxorubicin, 29 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/90\">",
"     90",
"    </a>",
"    ]). &nbsp;",
"   </p>",
"   <p>",
"    High-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    was combined with interferon-alfa and interferon-gamma in a series of 24 evaluable patients with advanced mesothelioma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/91\">",
"     91",
"    </a>",
"    ]. Seven (29 percent) had a partial response, and the one- and two-year survival rates were 62 and 31 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/91\">",
"     91",
"    </a>",
"    ]. A small study of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/27/4536?source=see_link\">",
"     epirubicin",
"    </a>",
"    plus IL-2 showed only one partial response among 25 patients with advanced disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/21/42329/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/15/33010?source=see_link\">",
"       \"Patient information: Pleural mesothelioma (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with advanced pleural mesotheliomas (MPM) who are not candidates for a combined modality approach that incorporates definitive surgery, we recommend treatment with combination chemotherapy using a platinum based doublet rather than single agent chemotherapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). This approach has been shown to significantly prolong overall survival compared with single agent chemotherapy using",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H1937732919\">",
"       'Combination chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Our preferred regimen is",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"       pemetrexed",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      , including prophylactic",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      and vitamin B12, based upon the more extensive clinical experience with this regimen. (See",
"      <a class=\"local\" href=\"#H1937732994\">",
"       'Pemetrexed plus cisplatin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other regimens that may be as effective but that have been studied less extensively include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"       pemetrexed",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38873?source=see_link\">",
"       carboplatin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/1/31769?source=see_link\">",
"       gemcitabine",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/1/21525?source=see_link\">",
"       raltitrexed",
"      </a>",
"      plus cisplatin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who progress on their initial platinum based doublet, we suggest single agent chemotherapy with an active agent such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/1/31769?source=see_link\">",
"       gemcitabine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/27/36279?source=see_link\">",
"       pemetrexed",
"      </a>",
"      that was not included in the original chemotherapy regimen (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Other older agents that also have some activity in MPM include anthracyclines and vinca alkaloids.",
"     </li>",
"     <li>",
"      The chemotherapy approaches used in the treatment of advanced MPM have been integrated into combined modality approaches along with definitive surgery and radiation therapy. These approaches are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/41/28312?source=see_link\">",
"       \"Treatment approaches for localized malignant pleural mesothelioma and solitary fibrous tumor of the pleura\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients should be included in formal clinical trials whenever possible.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/1\">",
"      Ong ST, Vogelzang NJ. Chemotherapy in malignant pleural mesothelioma. A review. J Clin Oncol 1996; 14:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/2\">",
"      Antman KH. Natural history and epidemiology of malignant mesothelioma. Chest 1993; 103:373S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/3\">",
"      Aisner J. Current approach to malignant mesothelioma of the pleura. Chest 1995; 107:332S.",
"     </a>",
"    </li>",
"    <li>",
"     American Joint Committee on Cancer. Pleural mesothelioma. In: Cancer Staging Manual, Seventh Edition, Springer, 2010. p.271.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/5\">",
"      Herndon JE, Green MR, Chahinian AP, et al. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 1998; 113:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/6\">",
"      Curran D, Sahmoud T, Therasse P, et al. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol 1998; 16:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/7\">",
"      Fennell DA, Parmar A, Shamash J, et al. Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials. J Clin Oncol 2005; 23:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/8\">",
"      Gordon GJ, Jensen RV, Hsiao LL, et al. Using gene expression ratios to predict outcome among patients with mesothelioma. J Natl Cancer Inst 2003; 95:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/9\">",
"      Pass HI, Liu Z, Wali A, et al. Gene expression profiles predict survival and progression of pleural mesothelioma. Clin Cancer Res 2004; 10:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/10\">",
"      Vogelzang NJ. Chemotherapy for malignant pleural mesothelioma. Lancet 2008; 371:1640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/11\">",
"      Francart J, Legrand C, Sylvester R, et al. Progression-free survival rate as primary end point for phase II cancer clinical trials: application to mesothelioma--The EORTC Lung Cancer Group. J Clin Oncol 2006; 24:3007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/12\">",
"      Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/13\">",
"      Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 2004; 15:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/14\">",
"      Nowak AK. CT, RECIST, and malignant pleural mesothelioma. Lung Cancer 2005; 49 Suppl 1:S37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/15\">",
"      Ceresoli GL, Chiti A, Zucali PA, et al. Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose. J Clin Oncol 2006; 24:4587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/16\">",
"      Wheatley-Price P, Yang B, Patsios D, et al. Soluble mesothelin-related Peptide and osteopontin as markers of response in malignant mesothelioma. J Clin Oncol 2010; 28:3316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/17\">",
"      Muers MF, Stephens RJ, Fisher P, et al. Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial. Lancet 2008; 371:1685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/18\">",
"      Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21:2636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/19\">",
"      Vogelzang NJ, Emri S, Boyer MJ, et al. Effect of folic acid and vitamin B12 supplmentation on risk-benefit ratio from phase III study of pemetrexed and cisplatin versus cisplatin in malignan pleural mesothelioma (abstract). Proc Am Soc Clin Oncol 2003; 22:657a.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/20\">",
"      Symanowski JT, Rusthoven J, Nguyen B, et al. Multiple regression analysis of prognostic variables for survival from the phase III study of pemetrexed plus cisplatin vs. cisplatin in malignant pleural mesothelioma (abstract). Proc Am Soc Clin Oncol 2003; 22:647a.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/21\">",
"      Righi L, Papotti MG, Ceppi P, et al. Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy. J Clin Oncol 2010; 28:1534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/22\">",
"      Ceresoli GL, Zucali PA, Favaretto AG, et al. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma. J Clin Oncol 2006; 24:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/23\">",
"      Castagneto B, Botta M, Aitini E, et al. Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM). Ann Oncol 2008; 19:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/24\">",
"      Santoro A, O'Brien ME, Stahel RA, et al. Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemona&iuml;ve patients with malignant pleural mesothelioma: results of the International Expanded Access Program. J Thorac Oncol 2008; 3:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/25\">",
"      Ceresoli GL, Castagneto B, Zucali PA, et al. Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials. Br J Cancer 2008; 99:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/26\">",
"      van Meerbeeck JP, Gaafar R, Manegold C, et al. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol 2005; 23:6881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/27\">",
"      Bottomley A, Gaafar R, Gaafa R, et al. Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study. J Clin Oncol 2006; 24:1435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/28\">",
"      Nowak AK, Byrne MJ, Williamson R, et al. A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma. Br J Cancer 2002; 87:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/29\">",
"      Castagneto B, Zai S, Dongiovanni D, et al. Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study. Am J Clin Oncol 2005; 28:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/30\">",
"      J&auml;nne PA, Simon GR, Langer CJ, et al. Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma. J Clin Oncol 2008; 26:1465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/31\">",
"      Kovac V, Zwitter M, Rajer M, et al. A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma. Anticancer Drugs 2012; 23:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/32\">",
"      Kindler HL, Karrison TG, Gandara DR, et al. Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma. J Clin Oncol 2012; 30:2509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/33\">",
"      Favaretto AG, Aversa SM, Paccagnella A, et al. Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study. Cancer 2003; 97:2791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/34\">",
"      Schutte W, Blankenburg T, Lauerwald K, et al. A multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma. Clin Lung Cancer 2003; 4:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/35\">",
"      Chahinian AP, Antman K, Goutsou M, et al. Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B. J Clin Oncol 1993; 11:1559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/36\">",
"      Ardizzoni A, Rosso R, Salvati F, et al. Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An Italian Lung Cancer Task Force (FONICAP) Phase II study. Cancer 1991; 67:2984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/37\">",
"      Henss H, Fiebig HH, Schildge J, et al. Phase-II study with the combination of cisplatin and doxorubicin in advanced malignant mesothelioma of the pleura. Onkologie 1988; 11:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/38\">",
"      Berghmans T, Lafitte JJ, Paesmans M, et al. A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma. Lung Cancer 2005; 50:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/39\">",
"      Hunt KJ, Longton G, Williams MA, Livingston RB. Treatment of malignant mesothelioma with methotrexate and vinblastine, with or without platinum chemotherapy. Chest 1996; 109:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/40\">",
"      Middleton GW, Smith IE, O'Brien ME, et al. Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma. Ann Oncol 1998; 9:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/41\">",
"      Berghmans T, Paesmans M, Lalami Y, et al. Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis. Lung Cancer 2002; 38:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/42\">",
"      Raghavan D, Gianoutsos P, Bishop J, et al. Phase II trial of carboplatin in the management of malignant mesothelioma. J Clin Oncol 1990; 8:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/43\">",
"      Vogelzang NJ, Goutsou M, Corson JM, et al. Carboplatin in malignant mesothelioma: a phase II study of the Cancer and Leukemia Group B. Cancer Chemother Pharmacol 1990; 27:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/44\">",
"      Scagliotti GV, Shin DM, Kindler HL, et al. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. J Clin Oncol 2003; 21:1556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/45\">",
"      Rusthoven JJ, Eisenhauer E, Butts C, et al. Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1999; 17:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/46\">",
"      Taylor P, Castagneto B, Dark G, et al. Single-agent pemetrexed for chemona&iuml;ve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program. J Thorac Oncol 2008; 3:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/47\">",
"      J&auml;nne PA, Wozniak AJ, Belani CP, et al. Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access program. J Thorac Oncol 2006; 1:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/48\">",
"      Jassem J, Ramlau R, Santoro A, et al. Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma. J Clin Oncol 2008; 26:1698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/49\">",
"      Manegold C, Symanowski J, Gatzemeier U, et al. Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma. Ann Oncol 2005; 16:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/50\">",
"      Solheim OP, Saeter G, Finnanger AM, Stenwig AE. High-dose methotrexate in the treatment of malignant mesothelioma of the pleura. A phase II study. Br J Cancer 1992; 65:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/51\">",
"      Kindler HL, Belani CP, Herndon JE 2nd, et al. Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B. Cancer 1999; 86:1985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/52\">",
"      Baas P, Ardizzoni A, Grossi F, et al. The activity of raltitrexed (Tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992). Eur J Cancer 2003; 39:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/53\">",
"      van Meerbeeck JP, Baas P, Debruyne C, et al. A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. Cancer 1999; 85:2577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/54\">",
"      Kindler HL, Millard F, Herndon JE 2nd, et al. Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B. Lung Cancer 2001; 31:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/55\">",
"      Lerner HJ, Schoenfeld DA, Martin A, et al. Malignant mesothelioma. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer 1983; 52:1981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/56\">",
"      Magri MD, Veronesi A, Foladore S, et al. Epirubicin in the treatment of malignant mesothelioma: a phase II cooperative study. The North-Eastern Italian Oncology Group (GOCCNE)--Mesothelioma Committee. Tumori 1991; 77:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/57\">",
"      Skubitz KM. Phase II trial of pegylated-liposomal doxorubicin (Doxil) in mesothelioma. Cancer Invest 2002; 20:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/58\">",
"      Steele JP, Shamash J, Evans MT, et al. Phase II study of vinorelbine in patients with malignant pleural mesothelioma. J Clin Oncol 2000; 18:3912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/59\">",
"      Talbot DC, Margery J, Dabouis G, et al. Phase II study of vinflunine in malignant pleural mesothelioma. J Clin Oncol 2007; 25:4751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/60\">",
"      Govindan R, Kratzke RA, Herndon JE 2nd, et al. Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B. Clin Cancer Res 2005; 11:2300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/61\">",
"      Garland LL, Rankin C, Gandara DR, et al. Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study. J Clin Oncol 2007; 25:2406.",
"     </a>",
"    </li>",
"    <li>",
"     Nowak AK, Millward MJ, Francis J, et al. Phase II study of sunitinib as second-line therapy in malignant pleural mesothelioma (MPM). J Clin Oncol 2008; 15s:8063. (Abstract available online at file://meeting.ascopubs.org/cgi/content/abstract/26/15_suppl/8063, accessed April 26, 2010).",
"    </li>",
"    <li>",
"     Karrison T, Kindler HL, Gandara DR, et al. Final analysis of a multi-center, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin (GC) plus bevacizumab (B) or placebo (P) in patients (pts) with malignant mesothelioma (MM)(abstract). J Clin Oncol 2007; 25:391s. (Abstract available online at: www.asco.org/portal/site/ASCO/menuitem.34d60f5624ba07fd506fe310ee37a01d/?vgnextoid=76f8201eb61a7010VgnVCM100000ed730ad1RCRD, accessed on June 20, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/64\">",
"      Van Schil PE, Baas P, Gaafar R, et al. Phase II feasibility trial of induction chemotherapy followed by extrapleural pneumonectomy and postoperative radiotherapy for cT3N1M0 or less malignant pleural mesothelioma (EORTC 08031) (abstract 7509). J Clin Oncol 2008; 27:384s.",
"     </a>",
"    </li>",
"    <li>",
"     National Institutes of Health Clinical Trials database www.clinicaltrials.gov (Accessed on June 27, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/66\">",
"      Mathy A, Baas P, Dalesio O, van Zandwijk N. Limited efficacy of imatinib mesylate in malignant mesothelioma: a phase II trial. Lung Cancer 2005; 50:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/67\">",
"      Porta C, Mutti L, Tassi G. Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma. Cancer Chemother Pharmacol 2007; 59:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/68\">",
"      Millward M, Parnis F, Byrne M, et al. Phase II trial of imatinib mesylate in patients with advanced pleural mesothelioma (abstract 912). Proc Am Soc Clin Oncol 2003; 22:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/69\">",
"      Jahan PA, Wang XF, Krug ML, et al. Sorafenib in malignant mesothelioma (MM): A phase II trial of the Cancer and Leukemia Group B (CALGB 30307) (abstract 7707). J Clin Oncol 2007; 25:18s.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/70\">",
"      Pavlakis N, Williams G, Harvey R, et al. Thalidomide alone and in combination with cisplatin/gemcitabine chemotherapy for malignant mesothelioma (MM): preliminary results from two phase II studies (abstract 1885). Proc Am Soc Clin Oncol 2002; 21:1885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/71\">",
"      Baas P, Boogerd W, Dalesio O, et al. Thalidomide in patients with malignant pleural mesothelioma. Lung Cancer 2005; 48:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/72\">",
"      Buikhuisen WA, Burgers JA, Vincent AD, et al. Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study. Lancet Oncol 2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/73\">",
"      Kelly WK, O'Connor OA, Krug LM, et al. Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer. J Clin Oncol 2005; 23:3923.",
"     </a>",
"    </li>",
"    <li>",
"     Krug LM, et al. Vorinostat in patients with advanced malignant pleural mesothelioma who have failed prior pemetrexed and either cisplatin or carboplatin therapy: A phase III, randomized, double-blind, placebo-controlled trial. ECCO-ESMO 2011; Abstract 3BA.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/75\">",
"      Mulatero CW, Penson RT, Papamichael D, et al. A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesothelioma. Lung Cancer 2001; 31:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/76\">",
"      Nowak AK, Lake RA, Kindler HL, Robinson BW. New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents. Semin Oncol 2002; 29:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/77\">",
"      Caminschi I, Venetsanakos E, Leong CC, et al. Interleukin-12 induces an effective antitumor response in malignant mesothelioma. Am J Respir Cell Mol Biol 1998; 19:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/78\">",
"      Hassan R, Ho M. Mesothelin targeted cancer immunotherapy. Eur J Cancer 2008; 44:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/79\">",
"      Palumbo C, Bei R, Procopio A, Modesti A. Molecular targets and targeted therapies for malignant mesothelioma. Curr Med Chem 2008; 15:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/80\">",
"      Hassan R, Zhang J, Pastan I. Antibody-based treatment for mesothelioma: Clinical trials and laboratory studies. Lung Cancer 2006; 54:S13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/81\">",
"      Hassan R, Bullock S, Premkumar A, et al. Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers. Clin Cancer Res 2007; 13:5144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/82\">",
"      Li Q, Verschraegen CF, Mendoza J, Hassan R. Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38, towards tumor cell lines established from ascites of patients with peritoneal mesotheliomas. Anticancer Res 2004; 24:1327.",
"     </a>",
"    </li>",
"    <li>",
"     Armstrong DK, Laheru D, Ma WW, et al. A phase I study of MORAb-009, a monoclonal antibody against mesothelin in pancreatic cancer, meesothelioma, and ovarian adenocarcinoma (abstract). J Clin Oncol 2007; 25:615s. (Abstraact available online at www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&amp;vmview=abst_detail_view&amp;confID=47&amp;abstractID=35576, accessed November 30, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/84\">",
"      Brockstedt DG, Giedlin MA, Leong ML, et al. Listeria-based cancer vaccines that segregate immunogenicity from toxicity. Proc Natl Acad Sci U S A 2004; 101:13832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/85\">",
"      Thomas AM, Santarsiero LM, Lutz ER, et al. Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients. J Exp Med 2004; 200:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/86\">",
"      Hassan R, Broaddus VC, Wilson S, et al. Anti-mesothelin immunotoxin SS1P in combination with gemcitabine results in increased activity against mesothelin-expressing tumor xenografts. Clin Cancer Res 2007; 13:7166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/87\">",
"      Hassan R, Ebel W, Routhier EL, et al. Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. Cancer Immun 2007; 7:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/88\">",
"      Trandafir L, Ruffi&eacute; P, Borel C, et al. Higher doses of alpha-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesothelioma. Eur J Cancer 1997; 33:1900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/89\">",
"      Upham JW, Musk AW, van Hazel G, et al. Interferon alpha and doxorubicin in malignant mesothelioma: a phase II study. Aust N Z J Med 1993; 23:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/90\">",
"      Parra HS, Tixi L, Latteri F, et al. Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP). Cancer 2001; 92:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/91\">",
"      Halme M, Knuuttila A, Vehmas T, et al. High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesothelioma. Br J Cancer 1999; 80:1781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/21/42329/abstract/92\">",
"      Bretti S, Berruti A, Dogliotti L, et al. Combined epirubicin and interleukin-2 regimen in the treatment of malignant mesothelioma: a multicenter phase II study of the Italian Group on Rare Tumors. Tumori 1998; 84:558.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4609 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-C9BE2142DC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42329=[""].join("\n");
var outline_f41_21_42329=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1937732754\">",
"      INITIAL EVALUATION AND CLINICAL APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1937732761\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1937732775\">",
"      Clinical approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3402924\">",
"      Prognostic factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3402931\">",
"      Response assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1937732919\">",
"      COMBINATION CHEMOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1937732994\">",
"      Pemetrexed plus cisplatin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1937733683\">",
"      Pemetrexed plus carboplatin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1937733690\">",
"      Raltitrexed plus cisplatin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3402373\">",
"      Gemcitabine plus cisplatin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3402445\">",
"      Other regimens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SINGLE AGENT CHEMOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3402150\">",
"      Platinum compounds",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3402035\">",
"      Pemetrexed",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3402298\">",
"      Other agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      EXPERIMENTAL APPROACHES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Molecularly targeted therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Immunotherapy and gene therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Chemoimmunotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/4609\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/4609|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?43/19/44349\" title=\"table 1\">",
"      TNM stage mesothelioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/54/36717\" title=\"table 2\">",
"      CALGB progn groups mesothelioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?20/7/20605\" title=\"table 3\">",
"      EORTC progn groups mesothelioma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/48/42764\" title=\"table 4\">",
"      RECIST response criteria solid tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/11/2236\" title=\"table 5\">",
"      Karnofsky performance status scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/50/32552?source=related_link\">",
"      Clinical presentation, diagnosis, and staging of malignant pleural mesothelioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/28/7622?source=related_link\">",
"      Epidemiology of malignant mesothelioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/33/29204?source=related_link\">",
"      Pathology of malignant pleural mesothelioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/15/33010?source=related_link\">",
"      Patient information: Pleural mesothelioma (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/41/28312?source=related_link\">",
"      Treatment approaches for localized malignant pleural mesothelioma and solitary fibrous tumor of the pleura",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_21_42330="Intermediate case 20";
var content_f41_21_42330=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F54006&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F54006&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1212px;\">",
"  <div class=\"figure\" style=\"width: 498px\">",
"   <div class=\"ttl\">",
"    Intermediate case 20",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 478px; height: 226px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42330=[""].join("\n");
var outline_f41_21_42330=null;
var title_f41_21_42331="Causes of gynecomastia";
var content_f41_21_42331=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F53468&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F53468&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Conditions associated with gynecomastia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Physiologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neonatal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pubertal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Involutional",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Pathologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Idiopathic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cirrhosis or malnutrition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Male hypogonadism - primary or secondary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Neoplasms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Testicular - germ cell, Leydig",
"cell, Sertoli cell, sex cord",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Adrenal - adenoma or carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ectopic production of human",
"chorionic gonadotropin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal disease and dialysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Rare causes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Enzymatic defects of testosterone production*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Androgen-insensitivity syndromes*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        True hermaphroditism*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Excessive extraglandular aromatase activity",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * These conditions are usually associated with ambiguity of genitalia or deficient virilization.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Braunstein, GD, N Engl J Med 1993; 328:490.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42331=[""].join("\n");
var outline_f41_21_42331=null;
var title_f41_21_42332="Exposures associated with ILD I";
var content_f41_21_42332=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F62236&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F62236&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Occupational and environmental exposures associated with interstitial lung disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Inhaled",
"organic dusts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        (hypersensitivity pneumonitis)",
"(Partial list)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"1\">",
"        Thermophilic fungi (ie,",
"Macropolyspora faeni, Thermactinomyces vulgaris, T. sacchari)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Farmer's lung&nbsp;&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Grain handler's lung",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Humidifier or air conditioner",
"lung",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Bacteria (ie, Bacillus subtilis, B. cereus)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Humidifier lung",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        True fungi (ie, Aspergillus,",
"Cryptostroma corticale, Aureobasidium pullulans, Penicillium species)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Animal proteins (eg, bird fancier's disease)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Inhaled agents other",
"than inorganic or organic dusts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Chemical sources",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Synthetic - fiber lung (Orlon,",
"polyesters, nylon, acrylic)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Bakelite worker's lung",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Vinyl chloride, polyvinyl",
"chloride powder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Gases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Oxygen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Oxides of nitrogen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Sulfur dioxide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Chlorine gas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Methyl isocyanate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Fumes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"1\">",
"        Oxides of",
"zinc, copper, manganese, cadmium, iron, magnesium, nickel, brass,",
"selenium, tin, and antimony",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Diphenylmethane diisocyanate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Trimellitic anhydride toxicity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Vapors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hydrocarbons",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Thermosetting resins (rubber",
"tire workers)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Toluene diisocyanate (TDI -",
"asthmatic reactions prominent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Mercury",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Aerosols",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Oils",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Fats",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pyrethrum (a natural insecticide)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Crystal, RG. Interstitial lung disease. In: Wyngaarden, JB, Smith, LH, Jr, Bennett, JC, (Eds), Cecil Textbook of Medicine, 19th ed, WB Saunders Co, Philadelphia, 1992.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42332=[""].join("\n");
var outline_f41_21_42332=null;
var title_f41_21_42333="FDA Daily Values for Food Labels";
var content_f41_21_42333=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70427&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70427&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Daily values for nutrients, set by the Food and Drug Administration for the purposes of food labeling",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Food component",
"       </td>",
"       <td class=\"subtitle1\">",
"        Daily value",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent of calories",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total fat*",
"       </td>",
"       <td>",
"        &lt;65 g",
"       </td>",
"       <td>",
"        &lt;30 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Saturated fat*",
"       </td>",
"       <td>",
"        &lt;20 g",
"       </td>",
"       <td>",
"        &lt;10 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cholesterol*",
"       </td>",
"       <td>",
"        &lt;300 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sodium*",
"       </td>",
"       <td>",
"        &lt;2400 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Potassium",
"       </td>",
"       <td>",
"        3500 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total carbohydrate",
"       </td>",
"       <td>",
"        300 g",
"       </td>",
"       <td>",
"        60 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dietary fiber",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        &ge;25 g",
"       </td>",
"       <td>",
"        &ge;12.5 g/1000 calories",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Protein",
"       </td>",
"       <td>",
"        50 g",
"       </td>",
"       <td>",
"        10 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin A",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        &ge;5000 IU",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin C",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        &ge;60 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calcium",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        &ge;1000 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Iron",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        &ge;18 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin D",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        400 IU",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin E",
"       </td>",
"       <td>",
"        30 IU",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin K",
"       </td>",
"       <td>",
"        80 micrograms",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thiamin",
"       </td>",
"       <td>",
"        1.5 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Riboflavin",
"       </td>",
"       <td>",
"        1.7 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Niacin",
"       </td>",
"       <td>",
"        20 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin B6",
"       </td>",
"       <td>",
"        2 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Folate",
"       </td>",
"       <td>",
"        400 micrograms",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin B12",
"       </td>",
"       <td>",
"        6 micrograms",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Biotin",
"       </td>",
"       <td>",
"        300 micrograms",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pantothenic acid",
"       </td>",
"       <td>",
"        10 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phosphorus",
"       </td>",
"       <td>",
"        1000 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Iodine",
"       </td>",
"       <td>",
"        150 micrograms",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Magnesium",
"       </td>",
"       <td>",
"        400 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zinc",
"       </td>",
"       <td>",
"        15 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Selenium",
"       </td>",
"       <td>",
"        70 micrograms",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Copper",
"       </td>",
"       <td>",
"        2 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Manganese",
"       </td>",
"       <td>",
"        2 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chromium",
"       </td>",
"       <td>",
"        120 micrograms",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Molybdenum",
"       </td>",
"       <td>",
"        75 micrograms",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chloride",
"       </td>",
"       <td>",
"        3400 mg",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    These Daily Values are based on a 2000 calorie diet. Note that these values should be adjusted for individuals whose energy intake is significantly above or below this level, including most children.",
"    <div class=\"footnotes\">",
"     g: grams; mg: milligrams; IU: international units; FDA: US food and drug administration.",
"     <br>",
"      * Daily Values for fat, cholesterol, and sodium are presented as the uppermost limit that it is desirable to consume, ie, individuals should consume less than this amount.",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       Daily Values for dietary fiber, vitamin A, vitamin C, calcium, and iron are presented as a lower limit that it is desirable to consume, ie, individuals should consume at least this amount.",
"       <br>",
"        &Delta; In 2011, the Food and Nutrition Board revised their Dietary Reference Intake recommendations for Vitamin D and Calcium. The FDA has not changed&nbsp;daily value&nbsp;targets.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: U.S. Food and Drug Administration. Guidance for Industry: A Food Labeling Guide (Revised October 2009). Available at",
"     <br>",
"      <a href=\"file://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodLabelingNutrition/FoodLabelingGuide/default.htm\" target=\"_blank\">",
"       file://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodLabelingNutrition/FoodLabelingGuide/default.htm",
"      </a>",
"      .",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42333=[""].join("\n");
var outline_f41_21_42333=null;
var title_f41_21_42334="Lat tibial avulsion fract";
var content_f41_21_42334=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F59493&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F59493&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Avulsion fracture of the lateral tibial condyle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 335px; height: 385px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This anteroposterior view of the knee demonstrates a small avulsion fracture of the lateral tibial condyle (arrow), consistent with a Segond fracture.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Shahla Modarresi, MD and Cecilia M Jude, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42334=[""].join("\n");
var outline_f41_21_42334=null;
var title_f41_21_42335="LA enlargement tutorial";
var content_f41_21_42335=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52162&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52162&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left atrial enlargement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 241px; height: 125px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The P wave in lead II is broad and substantially notched, while V1 reveals a deeply inverted (negative) P wave.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_21_42335=[""].join("\n");
var outline_f41_21_42335=null;
